{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:41:55Z","timestamp":1794573715656,"version":"4.9.1"},"reference-count":460,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH NINDS"},{"DOI":"10.13039\/100008552","name":"Brigham Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008552","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The complement system, a critical arm of innate immunity, has emerged as a key contributor to the pathogenesis of Alzheimer\u2019s disease (AD). While complement-mediated synaptic pruning is essential during brain development, its reactivation in the aging and diseased brain can promote neurodegeneration. In AD and cerebral amyloid angiopathy (CAA), aberrant complement activity contributes to amyloid-\u03b2 (A\u03b2) accumulation, synapse loss, neuroinflammation, vascular dysfunction and blood-brain barrier (BBB) disruption. This review traces the evolving understanding of complement dysregulation in AD, from foundational findings in human studies to mechanistic discoveries in animal models and emerging induced pluripotent stem cell (iPSC)-derived cellular systems. It describes how genetic and epigenetic factors, including risk variants, chromatin modifications, and microRNAs, modulate complement pathways in the AD brain. Systemic influences, such as gut-brain axis disruption, are also considered for their potential to exacerbate complement-mediated neuroinflammation in AD. We further highlight efforts to identify biomarkers of complement activation and review the therapeutic potential of targeting complement components and regulators. By integrating molecular, experimental, and translational perspectives, this review outlines the multifaceted involvement of complement in AD and discusses key directions for future research and therapeutic interventions.<\/jats:p>","DOI":"10.1186\/s13024-025-00916-y","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:45:34Z","timestamp":1765820734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The complement cascade in Alzheimer\u2019s disease: modern implications of an ancient immune protagonist"],"prefix":"10.1186","volume":"21","author":[{"given":"Maria-Tzousi","family":"Papavergi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Bathini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Lemere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"916_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther. 2023;8:267.","journal-title":"Signal Transduct Target Ther"},{"key":"916_CR2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3233\/JAD-160527","volume":"54","author":"M Vijayan","year":"2016","unstructured":"Vijayan M, Reddy PH. Stroke, vascular dementia, and alzheimer\u2019s disease: molecular links. J Alzheimers Dis. 2016;54:427\u201343.","journal-title":"J Alzheimers Dis"},{"key":"916_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-022-00523-1","volume":"17","author":"TE Golde","year":"2022","unstructured":"Golde TE. Alzheimer\u2019s disease \u2013 the journey of a healthy brain into organ failure. Mol Neurodegeneration. 2022;17:1\u201319.","journal-title":"Mol Neurodegeneration"},{"key":"916_CR4","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.tins.2023.03.005","volume":"46","author":"TL Young-Pearse","year":"2023","unstructured":"Young-Pearse TL, Lee H, Hsieh Y-C, Chou V, Selkoe DJ. Moving beyond amyloid and Tau to capture the biological heterogeneity of alzheimer\u2019s disease. Trends Neurosci. 2023;46:426\u201344.","journal-title":"Trends Neurosci"},{"key":"916_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/procel\/pwae026","volume":"16","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Wang X. Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy. Protein Cell. 2025;16:83\u2013120.","journal-title":"Protein Cell"},{"key":"916_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat Genet. 2019;51:414\u201330.","journal-title":"Nat Genet"},{"key":"916_CR7","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with alzheimer\u2019s disease. Nat Genet. 2009;41:1088\u201393.","journal-title":"Nat Genet"},{"key":"916_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/mp.2011.24","volume":"17","author":"N Brouwers","year":"2012","unstructured":"Brouwers N, Van Cauwenberghe C, Engelborghs S, Lambert J-C, Bettens K, Le Bastard N, et al. Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b\/C4b binding sites. Mol Psychiatry. 2012;17:223\u201333.","journal-title":"Mol Psychiatry"},{"key":"916_CR9","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"J-C Lambert","year":"2009","unstructured":"Lambert J-C, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. Genome-wide association study identifies variants at CLU and CR1 associated with alzheimer\u2019s disease. Nat Genet. 2009;41:1094\u20139.","journal-title":"Nat Genet"},{"key":"916_CR10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12974-020-02024-8","volume":"17","author":"ND Schartz","year":"2020","unstructured":"Schartz ND, Tenner AJ. The good, the bad, and the opportunities of the complement system in neurodegenerative disease. J Neuroinflammation. 2020;17:354.","journal-title":"J Neuroinflammation"},{"key":"916_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/imr.12474","volume":"274","author":"M Elvington","year":"2016","unstructured":"Elvington M, Liszewski MK, Atkinson JP. Evolution of the complement system: from defense of the single cell to guardian of the intravascular space. Immunol Rev. 2016;274:9\u201315.","journal-title":"Immunol Rev"},{"key":"916_CR12","doi-asserted-by":"publisher","first-page":"600656","DOI":"10.3389\/fncel.2020.600656","volume":"14","author":"BP Morgan","year":"2020","unstructured":"Morgan BP, Gommerman JL, Ramaglia V. An outside-in and inside-out consideration of complement in the multiple sclerosis brain: lessons from development and neurodegenerative diseases. Front Cell Neurosci. 2020;14:600656.","journal-title":"Front Cell Neurosci"},{"key":"916_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fimmu.2019.00362","volume":"10","author":"SM Carpanini","year":"2019","unstructured":"Carpanini SM, Torvell M, Morgan BP. Therapeutic Inhibition of the complement system in diseases of the central nervous system. Front Immunol. 2019;10:362.","journal-title":"Front Immunol"},{"key":"916_CR14","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","volume":"131","author":"B Stevens","year":"2007","unstructured":"Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, et al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131:1164\u201378.","journal-title":"Cell"},{"key":"916_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-neuro-061010-113810","volume":"35","author":"AH Stephan","year":"2012","unstructured":"Stephan AH, Barres BA, Stevens B. The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci. 2012;35:369\u201389.","journal-title":"Annu Rev Neurosci"},{"key":"916_CR16","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1523\/JNEUROSCI.3932-10.2011","volume":"31","author":"ME Benoit","year":"2011","unstructured":"Benoit ME, Tenner AJ. Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and MicroRNA expression. J Neurosci. 2011;31:3459\u201369.","journal-title":"J Neurosci"},{"key":"916_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1146\/annurev-immunol-101921-035639","volume":"41","author":"SS Bohlson","year":"2023","unstructured":"Bohlson SS, Tenner AJ. Complement in the brain: contributions to Neuroprotection, neuronal Plasticity, and neuroinflammation. Annu Rev Immunol. 2023;41:431\u201352.","journal-title":"Annu Rev Immunol"},{"key":"916_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-025-08713-9","volume":"641","author":"CA Donado","year":"2025","unstructured":"Donado CA, Theisen E, Zhang F, Nathan A, Fairfield ML, Rupani KV, et al. Granzyme K activates the entire complement cascade. Nature. 2025;641:211\u201321.","journal-title":"Nature"},{"issue":"5","key":"916_CR19","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41582-025-01073-y","volume":"21","author":"AJ Tenner","year":"2025","unstructured":"Tenner AJ, Petrisko TJ. Knowing the enemy: strategic targeting of complement to treat alzheimer disease. Nat Rev Neurol. 2025;21(5):250\u201364.","journal-title":"Nat Rev Neurol"},{"key":"916_CR20","doi-asserted-by":"publisher","first-page":"153089","DOI":"10.1016\/j.imbio.2025.153089","volume":"230","author":"WM Zelek","year":"2025","unstructured":"Zelek WM, Tenner AJ. Complement therapeutics in neurodegenerative diseases. Immunobiology. 2025;230:153089.","journal-title":"Immunobiology"},{"key":"916_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/7854_2024_524","volume":"69","author":"N Daskoulidou","year":"2025","unstructured":"Daskoulidou N, Carpanini SM, Zelek WM, Morgan BP. Involvement of complement in alzheimer\u2019s disease: from genetics through pathology to therapeutic strategies. Curr Top Behav Neurosci. 2025;69:3\u201324.","journal-title":"Curr Top Behav Neurosci"},{"key":"916_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1042\/CS20230513","volume":"138","author":"J Nimmo","year":"2024","unstructured":"Nimmo J, Byrne RAJ, Daskoulidou N, Watkins LM, Carpanini SM, Zelek WM, et al. The complement system in neurodegenerative diseases. Clin Sci (Lond). 2024;138:387\u2013412.","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"916_CR23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3390\/ijms25020817","volume":"25","author":"AF Batista","year":"2024","unstructured":"Batista AF, Khan KA, Papavergi MT, Lemere CA. The importance of Complement-Mediated immune signaling in alzheimer\u2019s disease pathogenesis. Int J Mol Sci. 2024;25(2):817.","journal-title":"Int J Mol Sci"},{"key":"916_CR24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.smim.2016.03.015","volume":"28","author":"FH Brennan","year":"2016","unstructured":"Brennan FH, Lee JD, Ruitenberg MJ, Woodruff TM. Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions. Semin Immunol. 2016;28:292\u2013308.","journal-title":"Semin Immunol"},{"key":"916_CR25","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/0197-4580(96)00113-3","volume":"17","author":"GM Pasinetti","year":"1996","unstructured":"Pasinetti GM. Inflammatory mechanisms in neurodegeneration and alzheimer\u2019s disease: the role of the complement system. Neurobiol Aging. 1996;17:707\u201316.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"916_CR26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3233\/JAD-160420","volume":"54","author":"S Hakobyan","year":"2016","unstructured":"Hakobyan S, Harding K, Aiyaz M, Hye A, Dobson R, Baird A, Liu B, Harris CL, Lovestone S, Morgan BP. Complement biomarkers as predictors of disease progression in alzheimer\u2019s disease. J Alzheimers Dis. 2016;54(2):707\u201316.","journal-title":"J Alzheimers Dis"},{"key":"916_CR27","unstructured":"Bordet J. Les leucocytes et les proprietes actives du serum Chez les vaccines. Ann Inst Pasteur. 1895:462\u2013506."},{"key":"916_CR28","doi-asserted-by":"crossref","unstructured":"Schmalstieg FC Jr, Goldman AS, Jules Bordet. (1870\u20131961): a Bridge between early and modern immunology. J Med Biogr. 2009;17:217\u201324.","DOI":"10.1258\/jmb.2009.009061"},{"key":"916_CR29","first-page":"699","volume":"10","author":"H Buchner","year":"1891","unstructured":"Buchner H. Zur nomenklatur der schutzenden Eiweisskorper. Centr Bakteriol Parasitenk. 1891;10:699\u2013701.","journal-title":"Centr Bakteriol Parasitenk"},{"key":"916_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1556\/EuJMI.2.2012.2.2","volume":"2","author":"PN Nesargikar","year":"2012","unstructured":"Nesargikar PN, Spiller B, Chavez R. The complement system: history, pathways, cascade and inhibitors. Eur J Microbiol Immunol (Bp). 2012;2:103\u201311.","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"916_CR31","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.3389\/fimmu.2019.02114","volume":"10","author":"J-M Cavaillon","year":"2019","unstructured":"Cavaillon J-M, Sansonetti P, Goldman M. 100th anniversary of Jules bordet\u2019s nobel prize: tribute to a founding father of immunology. Front Immunol. 2019;10:2114.","journal-title":"Front Immunol"},{"key":"916_CR32","unstructured":"Ehrlich P, Morgenroth J. Zweite mittheilung. Zweite mittheilung Berliner klinische Wochenschrift. 1899;36:481\u20136."},{"key":"916_CR33","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00251-006-0142-1","volume":"58","author":"M Nonaka","year":"2006","unstructured":"Nonaka M, Kimura A. Genomic view of the evolution of the complement system. Immunogenetics. 2006;58:701\u201313.","journal-title":"Immunogenetics"},{"key":"916_CR34","first-page":"719","volume":"16","author":"U Hadding","year":"1969","unstructured":"Hadding U, M\u00fcller-Eberhard HJ. The ninth component of human complement: isolation, description and mode of action. Immunology. 1969;16:719\u201335.","journal-title":"Immunology"},{"key":"916_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1699-0463.1967.tb01315.x","volume":"70","author":"U Nilsson","year":"1967","unstructured":"Nilsson U. Separation and partial purification of the sixth, seventh and eighth components of human haemolytic complement. Acta Pathol Microbiol Scand. 1967;70:469\u201380.","journal-title":"Acta Pathol Microbiol Scand"},{"key":"916_CR36","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1084\/jem.122.2.277","volume":"122","author":"UR Nilsson","year":"1965","unstructured":"Nilsson UR, Mueller-Eberhard HJ, ISOLATION OF BETA IF-GLOBULIN FROM, HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT. J Exp Med. 1965;122:277\u201398.","journal-title":"J Exp Med"},{"key":"916_CR37","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1084\/jem.118.3.447","volume":"118","author":"HJ Mueller-Eberhard","year":"1963","unstructured":"Mueller-Eberhard HJ, Biro CE. Isolation and description of the fourth component of human complement. J Exp Med. 1963;118:447\u201366.","journal-title":"J Exp Med"},{"key":"916_CR38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1126\/science.94.2445.437","volume":"94","author":"L Pillemer","year":"1941","unstructured":"Pillemer L, Ecker EE. The terminology of the components of complement. Science. 1941;94:437.","journal-title":"Science"},{"key":"916_CR39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/cr.2009.139","volume":"20","author":"JR Dunkelberger","year":"2010","unstructured":"Dunkelberger JR, Song W-C. Complement and its role in innate and adaptive immune responses. Cell Res. 2010;20:34\u201350.","journal-title":"Cell Res"},{"key":"916_CR40","first-page":"93","volume":"32","author":"MB Pepys","year":"1976","unstructured":"Pepys MB. Role of complement in the induction of immunological responses. Transpl Rev. 1976;32:93\u2013120.","journal-title":"Transpl Rev"},{"key":"916_CR41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1084\/jem.140.1.126","volume":"140","author":"MB Pepys","year":"1974","unstructured":"Pepys MB. Role of complement in induction of antibody production in vivo. Effect of Cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J Exp Med. 1974;140:126\u201345.","journal-title":"J Exp Med"},{"key":"916_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.imlet.2004.11.010","volume":"97","author":"BP Morgan","year":"2005","unstructured":"Morgan BP, Marchbank KJ, Longhi MP, Harris CL, Gallimore AM. Complement: central to innate immunity and bridging to adaptive responses. Immunol Lett. 2005;97:171\u20139.","journal-title":"Immunol Lett"},{"key":"916_CR43","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/ni1113","volume":"5","author":"MC Carroll","year":"2004","unstructured":"Carroll MC. The complement system in regulation of adaptive immunity. Nat Immunol. 2004;5:981\u20136.","journal-title":"Nat Immunol"},{"key":"916_CR44","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11:785\u201397.","journal-title":"Nat Immunol"},{"key":"916_CR45","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41577-023-00926-1","volume":"24","author":"DC Mastellos","year":"2024","unstructured":"Mastellos DC, Hajishengallis G, Lambris JD. A guide to complement biology, pathology and therapeutic opportunity. Nat Rev Immunol. 2024;24:118\u201341.","journal-title":"Nat Rev Immunol"},{"key":"916_CR46","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41581-023-00704-1","volume":"19","author":"EE West","year":"2023","unstructured":"West EE, Kemper C. Complosome - the intracellular complement system. Nat Rev Nephrol. 2023;19:426\u201339.","journal-title":"Nat Rev Nephrol"},{"key":"916_CR47","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","volume":"344","author":"MJ Walport","year":"2001","unstructured":"Walport MJ. Complement. First of two parts. N Engl J Med. 2001;344:1058\u201366.","journal-title":"N Engl J Med"},{"key":"916_CR48","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3390\/ijms25031566","volume":"25","author":"J Dob\u00f3","year":"2024","unstructured":"Dob\u00f3 J, Kocsis A, Farkas B, Demeter F, Cervenak L, G\u00e1l P. The lectin pathway of the complement system-activation, regulation, disease connections and interplay with other (proteolytic) systems. Int J Mol Sci. 2024;25:1566.","journal-title":"Int J Mol Sci"},{"key":"916_CR49","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/imr.13132","volume":"313","author":"MK Liszewski","year":"2023","unstructured":"Liszewski MK, Atkinson JP. Alternative pathway activation: ever ancient and ever new. Immunol Rev. 2023;313:60\u20133.","journal-title":"Immunol Rev"},{"key":"916_CR50","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1021\/bi500157z","volume":"53","author":"D Bubeck","year":"2014","unstructured":"Bubeck D. The making of a macromolecular machine: assembly of the membrane attack complex. Biochemistry. 2014;53:1908\u201315.","journal-title":"Biochemistry"},{"issue":"4","key":"916_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00232-025-00343-6","volume":"258","author":"BHT Ho","year":"2025","unstructured":"Ho BHT, Spicer BA, Dunstone MA. Action of the terminal complement pathway on cell membranes. J Membr Biol. 2025;258(4):269\u2013304.","journal-title":"J Membr Biol"},{"key":"916_CR52","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1177\/0192623311428478","volume":"40","author":"W-C Song","year":"2012","unstructured":"Song W-C. Crosstalk between complement and toll-like receptors. Toxicol Pathol. 2012;40:174\u201382.","journal-title":"Toxicol Pathol"},{"issue":"Suppl 1","key":"916_CR53","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1111\/jth.12950","volume":"13","author":"EM Conway","year":"2015","unstructured":"Conway EM. Reincarnation of ancient links between coagulation and complement. J Thromb Haemost. 2015;13(Suppl 1):S121\u201332.","journal-title":"J Thromb Haemost"},{"key":"916_CR54","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nri2620","volume":"9","author":"PF Zipfel","year":"2009","unstructured":"Zipfel PF, Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol. 2009;9:729\u201340.","journal-title":"Nat Rev Immunol"},{"key":"916_CR55","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrd4657","volume":"14","author":"BP Morgan","year":"2015","unstructured":"Morgan BP, Harris CL. Complement, a target for therapy in inflammatory and degenerative diseases. Nat Rev Drug Discov. 2015;14:857\u201377.","journal-title":"Nat Rev Drug Discov"},{"key":"916_CR56","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-immunol-032713-120154","volume":"32","author":"VM Holers","year":"2014","unstructured":"Holers VM. Complement and its receptors: new insights into human disease. Annu Rev Immunol. 2014;32:433\u201359.","journal-title":"Annu Rev Immunol"},{"key":"916_CR57","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.immuni.2013.10.018","volume":"39","author":"MK Liszewski","year":"2013","unstructured":"Liszewski MK, Kolev M, Le Friec G, Leung M, Bertram PG, Fara AF, et al. Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation. Immunity. 2013;39:1143\u201357.","journal-title":"Immunity"},{"key":"916_CR58","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nri3761","volume":"14","author":"M Kolev","year":"2014","unstructured":"Kolev M, Le Friec G, Kemper C. Complement\u2013tapping into new sites and effector systems. Nat Rev Immunol. 2014;14:811\u201320.","journal-title":"Nat Rev Immunol"},{"key":"916_CR59","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.immuni.2016.08.003","volume":"45","author":"C Hess","year":"2016","unstructured":"Hess C, Kemper C. Complement-mediated regulation of metabolism and basic cellular processes. Immunity. 2016;45:240\u201354.","journal-title":"Immunity"},{"key":"916_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.00001","volume":"8","author":"M Kolev","year":"2017","unstructured":"Kolev M, Kemper C. Keeping it all going-complement Meets metabolism. Front Immunol. 2017;8:1.","journal-title":"Front Immunol"},{"key":"916_CR61","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.molimm.2017.01.004","volume":"84","author":"MK Liszewski","year":"2017","unstructured":"Liszewski MK, Elvington M, Kulkarni HS, Atkinson JP. Complement\u2019s hidden arsenal: new insights and novel functions inside the cell. Mol Immunol. 2017;84:2\u20139.","journal-title":"Mol Immunol"},{"key":"916_CR62","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1080\/15548627.2019.1580515","volume":"15","author":"BC King","year":"2019","unstructured":"King BC, Renstr\u00f6m E, Blom AM. Intracellular cytosolic complement component C3 regulates cytoprotective autophagy in pancreatic beta cells by interaction with ATG16L1. Autophagy. 2019;15:919\u201321.","journal-title":"Autophagy"},{"key":"916_CR63","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.chom.2018.04.008","volume":"23","author":"MT Sorbara","year":"2018","unstructured":"Sorbara MT, Foerster EG, Tsalikis J, Abdel-Nour M, Mangiapane J, Sirluck-Schroeder I, et al. Complement C3 drives autophagy-dependent restriction of cyto-invasive bacteria. Cell Host Microbe. 2018;23:644\u2013e525.","journal-title":"Cell Host Microbe"},{"key":"916_CR64","doi-asserted-by":"publisher","first-page":"93","DOI":"10.15698\/mic2020.04.712","volume":"7","author":"C Viret","year":"2020","unstructured":"Viret C, Rozi\u00e8res A, Duclaux-Loras R, Boschetti G, Nancey S, Faure M. Regulation of anti-microbial autophagy by factors of the complement system. Microb Cell. 2020;7:93\u2013105.","journal-title":"Microb Cell"},{"key":"916_CR65","doi-asserted-by":"publisher","first-page":"e22037","DOI":"10.1096\/fj.202100856R","volume":"35","author":"Y Li","year":"2021","unstructured":"Li Y, Sha Y, Wang H, He L, Li L, Wen S, et al. Intracellular C3 prevents hepatic steatosis by promoting autophagy and very-low-density lipoprotein secretion. FASEB J. 2021;35:e22037.","journal-title":"FASEB J"},{"key":"916_CR66","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/ni.2454","volume":"13","author":"G Le Friec","year":"2012","unstructured":"Le Friec G, Sheppard D, Whiteman P, Karsten CM, Shamoun SA-T, Laing A, et al. The CD46-Jagged1 interaction is critical for human TH1 immunity. Nat Immunol. 2012;13:1213\u201321.","journal-title":"Nat Immunol"},{"key":"916_CR67","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.immuni.2015.05.024","volume":"42","author":"M Kolev","year":"2015","unstructured":"Kolev M, Dimeloe S, Le Friec G, Navarini A, Arbore G, Povoleri GA, et al. Complement regulates nutrient influx and metabolic reprogramming during Th1 cell responses. Immunity. 2015;42:1033\u201347.","journal-title":"Immunity"},{"key":"916_CR68","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1038\/s41467-018-06706-z","volume":"9","author":"G Arbore","year":"2018","unstructured":"Arbore G, West EE, Rahman J, Le Friec G, Niyonzima N, Pirooznia M, et al. Complement receptor CD46 co-stimulates optimal human CD8 + T cell effector function via fatty acid metabolism. Nat Commun. 2018;9:4186.","journal-title":"Nat Commun"},{"key":"916_CR69","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.omtn.2021.02.019","volume":"24","author":"J Zeng","year":"2021","unstructured":"Zeng J, Xu H, Huang C, Sun Y, Xiao H, Yu G, et al. CD46 splice variant enhances translation of specific mRNAs linked to an aggressive tumor cell phenotype in bladder cancer. Mol Ther Nucleic Acids. 2021;24:140\u201353.","journal-title":"Mol Ther Nucleic Acids"},{"key":"916_CR70","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3389\/fimmu.2019.00493","volume":"10","author":"M Kremlitzka","year":"2019","unstructured":"Kremlitzka M, Nowacka AA, Mohlin FC, Bompada P, De Marinis Y, Blom AM. Interaction of serum-derived and internalized C3 with DNA in human B cells-A potential involvement in regulation of gene transcription. Front Immunol. 2019;10:493.","journal-title":"Front Immunol"},{"key":"916_CR71","doi-asserted-by":"publisher","first-page":"379","DOI":"10.4049\/jimmunol.1900276","volume":"203","author":"J Paiano","year":"2019","unstructured":"Paiano J, Harland M, Strainic MG, Nedrud J, Hussain W, Medof ME. Follicular B2 cell activation and class switch recombination depend on autocrine C3ar1\/C5ar1 signaling in B2 cells. J Immunol. 2019;203:379\u201388.","journal-title":"J Immunol"},{"key":"916_CR72","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.immuni.2020.02.006","volume":"52","author":"M Kolev","year":"2020","unstructured":"Kolev M, West EE, Kunz N, Chauss D, Moseman EA, Rahman J, et al. Diapedesis-induced integrin signaling via LFA-1 facilitates tissue immunity by inducing intrinsic complement C3 expression in immune cells. Immunity. 2020;52:513\u2013e278.","journal-title":"Immunity"},{"key":"916_CR73","doi-asserted-by":"publisher","first-page":"eabf2489","DOI":"10.1126\/sciimmunol.abf2489","volume":"6","author":"N Niyonzima","year":"2021","unstructured":"Niyonzima N, Rahman J, Kunz N, West EE, Freiwald T, Desai JV, et al. Mitochondrial C5aR1 activity in macrophages controls IL-1\u03b2 production underlying sterile inflammation. Sci Immunol. 2021;6:eabf2489.","journal-title":"Sci Immunol"},{"key":"916_CR74","doi-asserted-by":"publisher","first-page":"5682","DOI":"10.4049\/jimmunol.1103760","volume":"188","author":"ME Benoit","year":"2012","unstructured":"Benoit ME, Clarke EV, Morgado P, Fraser DA, Tenner AJ. Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells. J Immunol. 2012;188:5682\u201393.","journal-title":"J Immunol"},{"key":"916_CR75","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1073\/pnas.1316877111","volume":"111","author":"L Baudino","year":"2014","unstructured":"Baudino L, Sardini A, Ruseva MM, Fossati-Jimack L, Cook HT, Scott D, et al. C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens. Proc Natl Acad Sci U S A. 2014;111:1503\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"916_CR76","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/cdd.2015.164","volume":"23","author":"M Martin","year":"2016","unstructured":"Martin M, Leffler J, Smol\u0105g KI, Mytych J, Bj\u00f6rk A, Chaves LD, et al. Factor H uptake regulates intracellular C3 activation during apoptosis and decreases the inflammatory potential of nucleosomes. Cell Death Differ. 2016;23:903\u201311.","journal-title":"Cell Death Differ"},{"key":"916_CR77","doi-asserted-by":"publisher","first-page":"769242","DOI":"10.3389\/fimmu.2021.769242","volume":"12","author":"N Sch\u00e4fer","year":"2021","unstructured":"Sch\u00e4fer N, Rasras A, Ormenisan DM, Amslinger S, Enzmann V, J\u00e4gle H, et al. Complement factor H-related 3 enhanced inflammation and complement activation in human RPE cells. Front Immunol. 2021;12:769242.","journal-title":"Front Immunol"},{"key":"916_CR78","doi-asserted-by":"publisher","first-page":"628062","DOI":"10.3389\/fimmu.2021.628062","volume":"12","author":"M Ishii","year":"2021","unstructured":"Ishii M, Beeson G, Beeson C, Rohrer B. Mitochondrial C3a receptor activation in oxidatively stressed epithelial cells reduces mitochondrial respiration and metabolism. Front Immunol. 2021;12:628062.","journal-title":"Front Immunol"},{"key":"916_CR79","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1165\/rcmb.2017-0405OC","volume":"60","author":"HS Kulkarni","year":"2019","unstructured":"Kulkarni HS, Elvington ML, Perng Y-C, Liszewski MK, Byers DE, Farkouh C, et al. Intracellular C3 protects human airway epithelial cells from stress-associated cell death. Am J Respir Cell Mol Biol. 2019;60:144\u201357.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"916_CR80","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.kint.2021.05.033","volume":"100","author":"S Mahajan","year":"2021","unstructured":"Mahajan S, Jacob A, Kelkar A, Chang A, Mcskimming D, Neelamegham S, et al. Local complement factor H protects kidney endothelial cell structure and function. Kidney Int. 2021;100:824\u201336.","journal-title":"Kidney Int"},{"key":"916_CR81","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.immuni.2021.03.003","volume":"54","author":"J Fri\u0161\u010di\u0107","year":"2021","unstructured":"Fri\u0161\u010di\u0107 J, B\u00f6ttcher M, Reinwald C, Bruns H, Wirth B, Popp S-J, et al. The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts. Immunity. 2021;54:1002\u2013e2110.","journal-title":"Immunity"},{"key":"916_CR82","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12974-019-1683-1","volume":"17","author":"D Datta","year":"2020","unstructured":"Datta D, Leslie SN, Morozov YM, Duque A, Rakic P, van Dyck CH, et al. Classical complement cascade initiating C1q protein within neurons in the aged rhesus macaque dorsolateral prefrontal cortex. J Neuroinflammation. 2020;17:8.","journal-title":"J Neuroinflammation"},{"key":"916_CR83","doi-asserted-by":"publisher","first-page":"e2120083119","DOI":"10.1073\/pnas.2120083119","volume":"119","author":"E Golec","year":"2022","unstructured":"Golec E, Ekstr\u00f6m A, Noga M, Omar-Hmeadi M, Lund P-E, Villoutreix BO, et al. Alternative splicing encodes functional intracellular CD59 isoforms that mediate insulin secretion and are down-regulated in diabetic Islets. Proc Natl Acad Sci U S A. 2022;119:e2120083119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"916_CR84","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.cmet.2018.09.009","volume":"29","author":"BC King","year":"2019","unstructured":"King BC, Kulak K, Krus U, Rosberg R, Golec E, Wozniak K, et al. Complement component C3 is highly expressed in human pancreatic Islets and prevents \u03b2 cell death via ATG16L1 interaction and autophagy regulation. Cell Metab. 2019;29:202\u2013e106.","journal-title":"Cell Metab"},{"key":"916_CR85","doi-asserted-by":"publisher","first-page":"eabg0833","DOI":"10.1126\/sciimmunol.abg0833","volume":"6","author":"B Yan","year":"2021","unstructured":"Yan B, Freiwald T, Chauss D, Wang L, West E, Mirabelli C, et al. SARS-CoV-2 drives JAK1\/2-dependent local complement hyperactivation. Sci Immunol. 2021;6:eabg0833.","journal-title":"Sci Immunol"},{"key":"916_CR86","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.molimm.2017.08.003","volume":"90","author":"A S\u00fcnderhauf","year":"2017","unstructured":"S\u00fcnderhauf A, Skibbe K, Preisker S, Ebbert K, Verschoor A, Karsten CM, et al. Regulation of epithelial cell expressed C3 in the intestine - Relevance for the pathophysiology of inflammatory bowel disease? Mol Immunol. 2017;90:227\u201338.","journal-title":"Mol Immunol"},{"key":"916_CR87","doi-asserted-by":"publisher","first-page":"788","DOI":"10.4049\/jimmunol.1502287","volume":"198","author":"A Satyam","year":"2017","unstructured":"Satyam A, Kannan L, Matsumoto N, Geha M, Lapchak PH, Bosse R, et al. Intracellular activation of complement 3 is responsible for intestinal tissue damage during mesenteric ischemia. J Immunol. 2017;198:788\u201397.","journal-title":"J Immunol"},{"key":"916_CR88","doi-asserted-by":"publisher","first-page":"575854","DOI":"10.3389\/fonc.2020.575854","volume":"10","author":"A S\u00fcnderhauf","year":"2020","unstructured":"S\u00fcnderhauf A, Raschdorf A, Hicken M, Schlichting H, Fetzer F, Brethack A-K, et al. GC1qR cleavage by caspase-1 drives aerobic Glycolysis in tumor cells. Front Oncol. 2020;10:575854.","journal-title":"Front Oncol"},{"key":"916_CR89","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1158\/2326-6066.CIR-20-0787","volume":"9","author":"MV Daugan","year":"2021","unstructured":"Daugan MV, Revel M, Thouenon R, Dragon-Durey M-A, Robe-Rybkine T, Torset C, et al. Intracellular factor H drives tumor progression independently of the complement cascade. Cancer Immunol Res. 2021;9:909\u201325.","journal-title":"Cancer Immunol Res"},{"key":"916_CR90","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1158\/2326-6066.CIR-20-0532","volume":"9","author":"MV Daugan","year":"2021","unstructured":"Daugan MV, Revel M, Russick J, Dragon-Durey M-A, Gaboriaud C, Robe-Rybkine T, et al. Complement C1s and C4d as prognostic biomarkers in renal cancer: emergence of noncanonical functions of C1s. Cancer Immunol Res. 2021;9:891\u2013908.","journal-title":"Cancer Immunol Res"},{"key":"916_CR91","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1111\/bph.15408","volume":"178","author":"D Portilla","year":"2021","unstructured":"Portilla D, Xavier S. Role of intracellular complement activation in kidney fibrosis. Br J Pharmacol. 2021;178:2880\u201391.","journal-title":"Br J Pharmacol"},{"key":"916_CR92","doi-asserted-by":"publisher","first-page":"15331","DOI":"10.3390\/ijms232315331","volume":"23","author":"M Tziastoudi","year":"2022","unstructured":"Tziastoudi M, Theoharides TC, Nikolaou E, Efthymiadi M, Eleftheriadis T, Stefanidis I. Key genetic components of fibrosis in diabetic nephropathy: an updated systematic review and meta-analysis. Int J Mol Sci. 2022;23:15331.","journal-title":"Int J Mol Sci"},{"key":"916_CR93","doi-asserted-by":"publisher","first-page":"1396520","DOI":"10.3389\/fneur.2024.1396520","volume":"15","author":"L Negro-Demontel","year":"2024","unstructured":"Negro-Demontel L, Maleki AF, Reich DS, Kemper C. The complement system in neurodegenerative and inflammatory diseases of the central nervous system. Front Neurol. 2024;15:1396520.","journal-title":"Front Neurol"},{"key":"916_CR94","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.tins.2018.03.009","volume":"41","author":"LG Coulthard","year":"2018","unstructured":"Coulthard LG, Hawksworth OA, Woodruff TM. Complement: the emerging architect of the developing brain. Trends Neurosci. 2018;41:373\u201384.","journal-title":"Trends Neurosci"},{"key":"916_CR95","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12974-020-01774-9","volume":"17","author":"J Pan","year":"2020","unstructured":"Pan J, Ma N, Yu B, Zhang W, Wan J. Transcriptomic profiling of microglia and astrocytes throughout aging. J Neuroinflammation. 2020;17:97.","journal-title":"J Neuroinflammation"},{"key":"916_CR96","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/s41593-019-0491-3","volume":"22","author":"M Ximerakis","year":"2019","unstructured":"Ximerakis M, Lipnick SL, Innes BT, Simmons SK, Adiconis X, Dionne D, et al. Single-cell transcriptomic profiling of the aging mouse brain. Nat Neurosci. 2019;22:1696\u2013708.","journal-title":"Nat Neurosci"},{"key":"916_CR97","doi-asserted-by":"publisher","first-page":"E1896","DOI":"10.1073\/pnas.1800165115","volume":"115","author":"LE Clarke","year":"2018","unstructured":"Clarke LE, Liddelow SA, Chakraborty C, M\u00fcnch AE, Heiman M, Barres BA. Normal aging induces A1-like astrocyte reactivity. Proc Natl Acad Sci U S A. 2018;115:E1896\u2013905.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"916_CR98","doi-asserted-by":"crossref","unstructured":"Petrisko TJ, Gomez-Arboledas A, Tenner AJ. Complement as a powerful influencer in the brain during development, adulthood and neurological disorders. Alt FW, Murphy KM, editors. Adv Immunol. 2021;152:157\u2013222.","DOI":"10.1016\/bs.ai.2021.09.003"},{"key":"916_CR99","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.3390\/ijms22041924","volume":"22","author":"PA Harcha","year":"2021","unstructured":"Harcha PA, Garc\u00e9s P, Arredondo C, Fern\u00e1ndez G, S\u00e1ez JC, van Zundert B. Mast cell and astrocyte hemichannels and their role in alzheimer\u2019s disease, ALS, and harmful stress conditions. Int J Mol Sci. 2021;22:1924.","journal-title":"Int J Mol Sci"},{"key":"916_CR100","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0022-3956(82)90038-3","volume":"17","author":"I Feinberg","year":"1982","unstructured":"Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res. 1982;17:319\u201334.","journal-title":"J Psychiatr Res"},{"key":"916_CR101","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","volume":"74","author":"DP Schafer","year":"2012","unstructured":"Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012;74:691\u2013705.","journal-title":"Neuron"},{"key":"916_CR102","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/glia.22389","volume":"61","author":"DP Schafer","year":"2013","unstructured":"Schafer DP, Lehrman EK, Stevens B. The quad-partite synapse: microglia-synapse interactions in the developing and mature CNS. Glia. 2013;61:24\u201336.","journal-title":"Glia"},{"key":"916_CR103","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.nbd.2013.02.003","volume":"54","author":"H Crehan","year":"2013","unstructured":"Crehan H, Hardy J, Pocock J. Blockage of CR1 prevents activation of rodent microglia. Neurobiol Dis. 2013;54:139\u201349.","journal-title":"Neurobiol Dis"},{"key":"916_CR104","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.1523\/JNEUROSCI.3850-15.2016","volume":"36","author":"T Iram","year":"2016","unstructured":"Iram T, Ramirez-Ortiz Z, Byrne MH, Coleman UA, Kingery ND, Means TK, et al. Megf10 is a receptor for C1Q that mediates clearance of apoptotic cells by astrocytes. J Neurosci. 2016;36:5185\u201392.","journal-title":"J Neurosci"},{"key":"916_CR105","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nature12776","volume":"504","author":"W-S Chung","year":"2013","unstructured":"Chung W-S, Clarke LE, Wang GX, Stafford BK, Sher A, Chakraborty C, et al. Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature. 2013;504:394\u2013400.","journal-title":"Nature"},{"key":"916_CR106","doi-asserted-by":"publisher","first-page":"10186","DOI":"10.1073\/pnas.1609896113","volume":"113","author":"W-S Chung","year":"2016","unstructured":"Chung W-S, Verghese PB, Chakraborty C, Joung J, Hyman BT, Ulrich JD, et al. Novel allele-dependent role for APOE in controlling the rate of synapse pruning by astrocytes. Proc Natl Acad Sci U S A. 2016;113:10186\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"916_CR107","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s43587-022-00281-1","volume":"2","author":"B Dejanovic","year":"2022","unstructured":"Dejanovic B, Wu T, Tsai M-C, Graykowski D, Gandham VD, Rose CM, et al. Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in alzheimer\u2019s disease mouse models. Nat Aging. 2022;2:837\u201350.","journal-title":"Nat Aging"},{"key":"916_CR108","doi-asserted-by":"publisher","first-page":"e2519253122","DOI":"10.1073\/pnas.2519253122","volume":"122","author":"BK Brott","year":"2025","unstructured":"Brott BK, Raissi AJ, Micheva KD, Vielmetter J, Mendes MS, Baccus CJ, et al. C4d, a high-affinity LilrB2 ligand, is elevated in alzheimer\u2019s disease and mediates synapse pruning. Proc Natl Acad Sci U S A. 2025;122:e2519253122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"916_CR109","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1523\/JNEUROSCI.1011-19.2019","volume":"40","author":"CA Welsh","year":"2020","unstructured":"Welsh CA, Stephany C-\u00c9, Sapp RW, Stevens B. Ocular dominance plasticity in binocular primary visual cortex does not require C1q. J Neurosci. 2020;40:769\u201383.","journal-title":"J Neurosci"},{"key":"916_CR110","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.4049\/jimmunol.176.7.4419","volume":"176","author":"DM Kraus","year":"2006","unstructured":"Kraus DM, Elliott GS, Chute H, Horan T, Pfenninger KH, Sanford SD, et al. CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues. J Immunol. 2006;176:4419\u201330.","journal-title":"J Immunol"},{"key":"916_CR111","doi-asserted-by":"publisher","first-page":"7028","DOI":"10.1038\/s41467-024-51163-6","volume":"15","author":"ND Schartz","year":"2024","unstructured":"Schartz ND, Liang HY, Carvalho K, Chu S-H, Mendoza-Arvilla A, Petrisko TJ, et al. C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an alzheimer\u2019s disease mouse model. Nat Commun. 2024;15:7028.","journal-title":"Nat Commun"},{"key":"916_CR112","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.bbi.2025.03.026","volume":"127","author":"RAJ Byrne","year":"2025","unstructured":"Byrne RAJ, Nimmo J, Torvell M, Carpanini SM, Daskoulidou N, Hughes TR, et al. The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humans. Brain Behav Immun. 2025;127:287\u2013302.","journal-title":"Brain Behav Immun"},{"key":"916_CR113","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0006-291X(03)01555-9","volume":"309","author":"A Shimizu","year":"2003","unstructured":"Shimizu A, Asakawa S, Sasaki T, Yamazaki S, Yamagata H, Kudoh J, et al. A novel giant gene CSMD3 encoding a protein with CUB and Sushi multiple domains: a candidate gene for benign adult Familial myoclonic epilepsy on human chromosome 8q23.3-q24.1. Biochem Biophys Res Commun. 2003;309:143\u201354.","journal-title":"Biochem Biophys Res Commun"},{"key":"916_CR114","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.bbi.2022.02.027","volume":"102","author":"W Song","year":"2022","unstructured":"Song W, Li Q, Wang T, Li Y, Fan T, Zhang J, et al. Putative complement control protein CSMD3 dysfunction impairs synaptogenesis and induces neurodevelopmental disorders. Brain Behav Immun. 2022;102:237\u201350.","journal-title":"Brain Behav Immun"},{"key":"916_CR115","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.2353\/ajpath.2010.091036","volume":"176","author":"Z Tu","year":"2010","unstructured":"Tu Z, Cohen M, Bu H, Lin F. Tissue distribution and functional analysis of Sushi domain-containing protein 4. Am J Pathol. 2010;176:2378\u201384.","journal-title":"Am J Pathol"},{"key":"916_CR116","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1096\/fj.12-222042","volume":"27","author":"E Holmquist","year":"2013","unstructured":"Holmquist E, Okroj M, Nodin B, Jirstr\u00f6m K, Blom AM. Sushi domain-containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertase. FASEB J. 2013;27:2355\u201366.","journal-title":"FASEB J"},{"key":"916_CR117","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1471-2156-8-72","volume":"8","author":"B Royer","year":"2007","unstructured":"Royer B, Soares DC, Barlow PN, Bontrop RE, Roll P, Robaglia-Schlupp A, et al. Molecular evolution of the human SRPX2 gene that causes brain disorders of the Rolandic and Sylvian speech areas. BMC Genet. 2007;8:72.","journal-title":"BMC Genet"},{"key":"916_CR118","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/s41593-020-0672-0","volume":"23","author":"Q Cong","year":"2020","unstructured":"Cong Q, Soteros BM, Wollet M, Kim JH, Sia G-M. The endogenous neuronal complement inhibitor SRPX2 protects against complement-mediated synapse elimination during development. Nat Neurosci. 2020;23:1067\u201378.","journal-title":"Nat Neurosci"},{"key":"916_CR119","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/glia.24114","volume":"70","author":"Q Cong","year":"2022","unstructured":"Cong Q, Soteros BM, Huo A, Li Y, Tenner AJ, Sia GM. C1q and SRPX2 regulate microglia mediated synapse elimination during early development in the visual thalamus but not the visual cortex. Glia. 2022;70:451\u201365.","journal-title":"Glia"},{"key":"916_CR120","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/dneu.22024","volume":"72","author":"AS Brown","year":"2012","unstructured":"Brown AS. Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Dev Neurobiol. 2012;72:1272\u20136.","journal-title":"Dev Neurobiol"},{"key":"916_CR121","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature16549","volume":"530","author":"A Sekar","year":"2016","unstructured":"Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530:177\u201383.","journal-title":"Nature"},{"key":"916_CR122","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41593-020-00763-8","volume":"24","author":"M Yilmaz","year":"2021","unstructured":"Yilmaz M, Yalcin E, Presumey J, Aw E, Ma M, Whelan CW, et al. Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice. Nat Neurosci. 2021;24:214\u201324.","journal-title":"Nat Neurosci"},{"key":"916_CR123","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.1038\/s41467-018-07785-8","volume":"9","author":"G Ponath","year":"2018","unstructured":"Ponath G, Lincoln MR, Levine-Ritterman M, Park C, Dahlawi S, Mubarak M, et al. Enhanced astrocyte responses are driven by a genetic risk allele associated with multiple sclerosis. Nat Commun. 2018;9:5337.","journal-title":"Nat Commun"},{"key":"916_CR124","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1093\/brain\/awz188","volume":"142","author":"KC Fitzgerald","year":"2019","unstructured":"Fitzgerald KC, Kim K, Smith MD, Aston SA, Fioravante N, Rothman AM, et al. Early complement genes are associated with visual system degeneration in multiple sclerosis. Brain. 2019;142:2722\u201336.","journal-title":"Brain"},{"key":"916_CR125","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.immuni.2019.12.004","volume":"52","author":"S Werneburg","year":"2020","unstructured":"Werneburg S, Jung J, Kunjamma RB, Ha S-K, Luciano NJ, Willis CM, et al. Targeted complement Inhibition at synapses prevents microglial synaptic engulfment and synapse loss in demyelinating disease. Immunity. 2020;52:167\u2013e827.","journal-title":"Immunity"},{"key":"916_CR126","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.3390\/ijms19123753","volume":"19","author":"K Krukowski","year":"2018","unstructured":"Krukowski K, Chou A, Feng X, Tiret B, Paladini M-S, Riparip L-K, et al. Traumatic brain injury in aged mice induces chronic microglia activation, synapse loss, and complement-dependent memory deficits. Int J Mol Sci. 2018;19:3753.","journal-title":"Int J Mol Sci"},{"key":"916_CR127","doi-asserted-by":"publisher","first-page":"E4367","DOI":"10.1073\/pnas.1521083113","volume":"113","author":"JS Siegel","year":"2016","unstructured":"Siegel JS, Ramsey LE, Snyder AZ, Metcalf NV, Chacko RV, Weinberger K, et al. Disruptions of network connectivity predict impairment in multiple behavioral domains after stroke. Proc Natl Acad Sci U S A. 2016;113:E4367\u201376.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"916_CR128","doi-asserted-by":"publisher","first-page":"e96505","DOI":"10.1371\/journal.pone.0096505","volume":"9","author":"Y Sun","year":"2014","unstructured":"Sun Y, Yin Q, Fang R, Yan X, Wang Y, Bezerianos A, et al. Disrupted functional brain connectivity and its association to structural connectivity in amnestic mild cognitive impairment and alzheimer\u2019s disease. PLoS ONE. 2014;9:e96505.","journal-title":"PLoS ONE"},{"key":"916_CR129","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.1038\/tp.2014.70","volume":"4","author":"S Nardone","year":"2014","unstructured":"Nardone S, Sams DS, Reuveni E, Getselter D, Oron O, Karpuj M, et al. DNA methylation analysis of the autistic brain reveals multiple dysregulated biological pathways. Transl Psychiatry. 2014;4:e433.","journal-title":"Transl Psychiatry"},{"key":"916_CR130","doi-asserted-by":"publisher","first-page":"7579","DOI":"10.3390\/ijms22147579","volume":"22","author":"F Mansur","year":"2021","unstructured":"Mansur F, Teles E, Silva AL, Gomes AKS, Magdalon J, de Souza JS, Griesi-Oliveira K, et al. Complement C4 is reduced in iPSC-derived astrocytes of autism spectrum disorder subjects. Int J Mol Sci. 2021;22:7579.","journal-title":"Int J Mol Sci"},{"key":"916_CR131","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/sj.emboj.7601004","volume":"25","author":"Y Rahpeymai","year":"2006","unstructured":"Rahpeymai Y, Hietala MA, Wilhelmsson U, Fotheringham A, Davies I, Nilsson A-K, et al. Complement: a novel factor in basal and ischemia-induced neurogenesis. EMBO J. 2006;25:1364\u201374.","journal-title":"EMBO J"},{"key":"916_CR132","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bbi.2021.08.215","volume":"98","author":"LJ Westacott","year":"2021","unstructured":"Westacott LJ, Haan N, Evison C, Marei O, Hall J, Hughes TR, et al. Dissociable effects of complement C3 and C3aR on survival and morphology of adult born hippocampal neurons, pattern separation, and cognitive flexibility in male mice. Brain Behav Immun. 2021;98:136\u201350.","journal-title":"Brain Behav Immun"},{"key":"916_CR133","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/ana.24398","volume":"77","author":"I Michailidou","year":"2015","unstructured":"Michailidou I, Willems JGP, Kooi E-J, van Eden C, Gold SM, Geurts JJG, et al. Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus: complement and synapses in MS. Ann Neurol. 2015;77:1007\u201326.","journal-title":"Ann Neurol"},{"key":"916_CR134","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12974-016-0611-x","volume":"13","author":"LM Watkins","year":"2016","unstructured":"Watkins LM, Neal JW, Loveless S, Michailidou I, Ramaglia V, Rees MI, et al. Complement is activated in progressive multiple sclerosis cortical grey matter lesions. J Neuroinflammation. 2016;13:161.","journal-title":"J Neuroinflammation"},{"key":"916_CR135","doi-asserted-by":"publisher","first-page":"eaao6459","DOI":"10.1126\/scitranslmed.aao6459","volume":"10","author":"A Alawieh","year":"2018","unstructured":"Alawieh A, Langley EF, Tomlinson S. Targeted complement Inhibition salvages stressed neurons and inhibits neuroinflammation after stroke in mice. Sci Transl Med. 2018;10:eaao6459.","journal-title":"Sci Transl Med"},{"key":"916_CR136","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0165-0173(98)00015-0","volume":"27","author":"PF Stahel","year":"1998","unstructured":"Stahel PF, Morganti-Kossmann MC, Kossmann T. The role of the complement system in traumatic brain injury. Brain Res Brain Res Rev. 1998;27:243\u201356.","journal-title":"Brain Res Brain Res Rev"},{"key":"916_CR137","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.4049\/jimmunol.1302793","volume":"192","author":"K Fluiter","year":"2014","unstructured":"Fluiter K, Opperhuizen AL, Morgan BP, Baas F, Ramaglia V. Inhibition of the membrane attack complex of the complement system reduces secondary neuroaxonal loss and promotes neurologic recovery after traumatic brain injury in mice. J Immunol. 2014;192:2339\u201348.","journal-title":"J Immunol"},{"key":"916_CR138","doi-asserted-by":"publisher","first-page":"e093183","DOI":"10.1002\/alz.093183","volume":"20","author":"P Bathini","year":"2025","unstructured":"Bathini P, Schilling S, Lemere CA. Anti-Amyloid immunotherapy for AD: A potential link between ARIA and complement. Alzheimer\u2019s Dement. 2025;20:e093183.","journal-title":"Alzheimer\u2019s Dement"},{"key":"916_CR139","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/s41591-025-03574-1","volume":"31","author":"L van Olst","year":"2025","unstructured":"van Olst L, Simonton B, Edwards AJ, Forsyth AV, Boles J, Jamshidi P, et al. Microglial mechanisms drive amyloid-\u03b2 clearance in immunized patients with alzheimer\u2019s disease. Nat Med. 2025;31:1604\u201316.","journal-title":"Nat Med"},{"key":"916_CR140","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S1474-4422(25)00313-8","volume":"24","author":"BDC Boon","year":"2025","unstructured":"Boon BDC, Piura YD, Moloney CM, Chalk JL, Lincoln SJ, Rutledge MH, et al. Neuropathological changes and amyloid-related imaging abnormalities in alzheimer\u2019s disease treated with aducanumab versus untreated: a retrospective case-control study. Lancet Neurol. 2025;24:931\u201344.","journal-title":"Lancet Neurol"},{"key":"916_CR141","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10014-016-0255-7","volume":"33","author":"M Ueno","year":"2016","unstructured":"Ueno M, Chiba Y, Murakami R, Matsumoto K, Kawauchi M, Fujihara R. Blood-brain barrier and blood-cerebrospinal fluid barrier in normal and pathological conditions. Brain Tumor Pathol. 2016;33:89\u201396.","journal-title":"Brain Tumor Pathol"},{"key":"916_CR142","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.tins.2020.12.002","volume":"44","author":"M Segarra","year":"2021","unstructured":"Segarra M, Aburto MR, Acker-Palmer A. Blood-brain barrier dynamics to maintain brain homeostasis. Trends Neurosci. 2021;44:393\u2013405.","journal-title":"Trends Neurosci"},{"key":"916_CR143","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cns.13569","volume":"27","author":"X Huang","year":"2021","unstructured":"Huang X, Hussain B, Chang J. Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms. CNS Neurosci Ther. 2021;27:36\u201347.","journal-title":"CNS Neurosci Ther"},{"key":"916_CR144","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","volume":"57","author":"BV Zlokovic","year":"2008","unstructured":"Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57:178\u2013201.","journal-title":"Neuron"},{"key":"916_CR145","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/01.WCB.0000078322.96027.78","volume":"23","author":"GJ del Zoppo","year":"2003","unstructured":"del Zoppo GJ, Mabuchi T. Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab. 2003;23:879\u201394.","journal-title":"J Cereb Blood Flow Metab"},{"key":"916_CR146","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2174\/156720208783565645","volume":"5","author":"C Kaur","year":"2008","unstructured":"Kaur C, Ling EA. Blood brain barrier in hypoxic-ischemic conditions. Curr Neurovasc Res. 2008;5:71\u201381.","journal-title":"Curr Neurovasc Res"},{"key":"916_CR147","doi-asserted-by":"publisher","first-page":"101340","DOI":"10.1016\/j.smim.2019.101340","volume":"45","author":"JD Lee","year":"2019","unstructured":"Lee JD, Coulthard LG, Woodruff TM. Complement dysregulation in the central nervous system during development and disease. Semin Immunol. 2019;45:101340.","journal-title":"Semin Immunol"},{"key":"916_CR148","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","volume":"33","author":"MA Erickson","year":"2013","unstructured":"Erickson MA, Banks WA. Blood-brain barrier dysfunction as a cause and consequence of alzheimer\u2019s disease. J Cereb Blood Flow Metab. 2013;33:1500\u201313.","journal-title":"J Cereb Blood Flow Metab"},{"key":"916_CR149","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.molimm.2014.06.039","volume":"61","author":"A Jacob","year":"2014","unstructured":"Jacob A, Alexander JJ. Complement and blood-brain barrier integrity. Mol Immunol. 2014;61:149\u201352.","journal-title":"Mol Immunol"},{"key":"916_CR150","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.molimm.2018.06.267","volume":"102","author":"JJ Alexander","year":"2018","unstructured":"Alexander JJ. Blood-brain barrier (BBB) and the complement landscape. Mol Immunol. 2018;102:26\u201331.","journal-title":"Mol Immunol"},{"key":"916_CR151","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1172\/JCI135530","volume":"130","author":"C Iadecola","year":"2020","unstructured":"Iadecola C, Buckwalter MS, Anrather J. Immune responses to stroke: mechanisms, modulation, and therapeutic potential. J Clin Invest. 2020;130:2777\u201388.","journal-title":"J Clin Invest"},{"issue":"16","key":"916_CR152","doi-asserted-by":"publisher","first-page":"12699","DOI":"10.3390\/ijms241612699","volume":"24","author":"S Brandl","year":"2023","unstructured":"Brandl S, Reindl M. Blood-Brain barrier breakdown in neuroinflammation: current in vitro models. Int J Mol Sci. 2023;24(16):12699.","journal-title":"Int J Mol Sci"},{"key":"916_CR153","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12987-024-00555-3","volume":"21","author":"A Delvenne","year":"2024","unstructured":"Delvenne A, Vandendriessche C, Gobom J, Burgelman M, Dujardin P, De Nolf C, et al. Involvement of the choroid plexus in alzheimer\u2019s disease pathophysiology: findings from mouse and human proteomic studies. Fluids Barriers CNS. 2024;21:58.","journal-title":"Fluids Barriers CNS"},{"key":"916_CR154","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00685397","volume":"57","author":"P Eikelenboom","year":"1982","unstructured":"Eikelenboom P, Stam FC. Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study. Acta Neuropathol. 1982;57:239\u201342.","journal-title":"Acta Neuropathol"},{"key":"916_CR155","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/BF00687336","volume":"63","author":"T Ishii","year":"1984","unstructured":"Ishii T, Haga S. Immuno-electron-microscopic localization of complements in amyloid fibrils of senile plaques. Acta Neuropathol. 1984;63:296\u2013300.","journal-title":"Acta Neuropathol"},{"key":"916_CR156","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1212\/WNL.42.2.447","volume":"42","author":"PL McGeer","year":"1992","unstructured":"McGeer PL, Rogers J. Anti-inflammatory agents as a therapeutic approach to alzheimer\u2019s disease. Neurology. 1992;42:447\u20139.","journal-title":"Neurology"},{"key":"916_CR157","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","volume":"21","author":"PL McGeer","year":"1995","unstructured":"McGeer PL, McGeer EG. The inflammatory response system of brain: implications for therapy of alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev. 1995;21:195\u2013218.","journal-title":"Brain Res Brain Res Rev"},{"key":"916_CR158","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0304-3940(89)90843-4","volume":"107","author":"PL McGeer","year":"1989","unstructured":"McGeer PL, Akiyama H, Itagaki S, McGeer EG. Activation of the classical complement pathway in brain tissue of alzheimer patients. Neurosci Lett. 1989;107:341\u20136.","journal-title":"Neurosci Lett"},{"key":"916_CR159","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1006\/exnr.1996.0043","volume":"138","author":"A Afagh","year":"1996","unstructured":"Afagh A, Cummings BJ, Cribbs DH, Cotman CW, Tenner AJ. Localization and cell association of C1q in alzheimer\u2019s disease brain. Exp Neurol. 1996;138:22\u201332.","journal-title":"Exp Neurol"},{"key":"916_CR160","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/BF00192116","volume":"426","author":"R Veerhuis","year":"1995","unstructured":"Veerhuis R, van der Valk P, Janssen I, Zhan SS, Van Nostrand WE, Eikelenboom P. Complement activation in amyloid plaques in alzheimer\u2019s disease brains does not proceed further than C3. Virchows Arch. 1995;426:603\u201310.","journal-title":"Virchows Arch"},{"key":"916_CR161","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s004019570001","volume":"91","author":"R Veerhuis","year":"1996","unstructured":"Veerhuis R, Janssen I, Hack CE, Eikelenboom P. Early complement components in alzheimer\u2019s disease brains. Acta Neuropathol. 1996;91:53\u201360.","journal-title":"Acta Neuropathol"},{"key":"916_CR162","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/0006-8993(94)91640-3","volume":"645","author":"S Itagaki","year":"1994","unstructured":"Itagaki S, Akiyama H, Saito H, McGeer PL. Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with alzheimer\u2019s disease. Brain Res. 1994;645:78\u201384.","journal-title":"Brain Res"},{"key":"916_CR163","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0197-4580(97)00042-0","volume":"18","author":"S Webster","year":"1997","unstructured":"Webster S, Lue LF, Brachova L, Tenner AJ, McGeer PL, Terai K, et al. Molecular and cellular characterization of the membrane attack complex, C5b-9, in alzheimer\u2019s disease. Neurobiol Aging. 1997;18:415\u201321.","journal-title":"Neurobiol Aging"},{"key":"916_CR164","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0002-9440(10)65340-0","volume":"154","author":"K Yasojima","year":"1999","unstructured":"Yasojima K, Schwab C, McGeer EG, McGeer PL. Up-regulated production and activation of the complement system in alzheimer\u2019s disease brain. Am J Pathol. 1999;154:927\u201336.","journal-title":"Am J Pathol"},{"key":"916_CR165","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.pneurobio.2003.08.001","volume":"70","author":"Y Shen","year":"2003","unstructured":"Shen Y, Meri S. Yin and yang: complement activation and regulation in alzheimer\u2019s disease. Prog Neurobiol. 2003;70:463\u201372.","journal-title":"Prog Neurobiol"},{"key":"916_CR166","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Inflammation and alzheimer\u2019s disease. Neurobiol Aging. 2000;21:383\u2013421.","journal-title":"Neurobiol Aging"},{"key":"916_CR167","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0197-4580(01)00301-3","volume":"22","author":"AJ Tenner","year":"2001","unstructured":"Tenner AJ. Complement in alzheimer\u2019s disease: opportunities for modulating protective and pathogenic events. Neurobiol Aging. 2001;22:849\u201361.","journal-title":"Neurobiol Aging"},{"key":"916_CR168","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0002-9440(10)64753-0","volume":"156","author":"SE Stoltzner","year":"2000","unstructured":"Stoltzner SE, Grenfell TJ, Mori C, Wisniewski KE, Wisniewski TM, Selkoe DJ, et al. Temporal accrual of complement proteins in amyloid plaques in down\u2019s syndrome with alzheimer\u2019s disease. Am J Pathol. 2000;156:489\u201399.","journal-title":"Am J Pathol"},{"key":"916_CR169","first-page":"1531","volume":"150","author":"S Webster","year":"1997","unstructured":"Webster S, Bonnell B, Rogers J. Charge-based binding of complement component C1q to the alzheimer amyloid beta-peptide. Am J Pathol. 1997;150:1531\u20136.","journal-title":"Am J Pathol"},{"key":"916_CR170","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1006\/exnr.1999.7260","volume":"161","author":"SD Webster","year":"2000","unstructured":"Webster SD, Yang AJ, Margol L, Garzon-Rodriguez W, Glabe CG, Tenner AJ. Complement component C1q modulates the phagocytosis of Abeta by microglia. Exp Neurol. 2000;161:127\u201338.","journal-title":"Exp Neurol"},{"key":"916_CR171","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.4049\/jimmunol.167.11.6374","volume":"167","author":"P Tacnet-Delorme","year":"2001","unstructured":"Tacnet-Delorme P, Chevallier S, Arlaud GJ. Beta-amyloid fibrils activate the C1 complex of complement under physiological conditions: evidence for a binding site for A beta on the C1q globular regions. J Immunol. 2001;167:6374\u201381.","journal-title":"J Immunol"},{"key":"916_CR172","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0304-3940(01)01842-0","volume":"305","author":"Y Shen","year":"2001","unstructured":"Shen Y, Lue L, Yang L, Roher A, Kuo Y, Strohmeyer R, et al. Complement activation by neurofibrillary tangles in alzheimer\u2019s disease. Neurosci Lett. 2001;305:165\u20138.","journal-title":"Neurosci Lett"},{"key":"916_CR173","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1365-2990.2005.00652.x","volume":"31","author":"M Tanskanen","year":"2005","unstructured":"Tanskanen M, Lindsberg PJ, Tienari PJ, Polvikoski T, Sulkava R, Verkkoniemi A, et al. Cerebral amyloid angiopathy in a 95 + cohort: complement activation and Apolipoprotein E (ApoE) genotype. Neuropathol Appl Neurobiol. 2005;31:589\u201399.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"916_CR174","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.neurobiolaging.2005.09.043","volume":"27","author":"J Rogers","year":"2006","unstructured":"Rogers J, Li R, Mastroeni D, Grover A, Leonard B, Ahern G, et al. Peripheral clearance of amyloid beta peptide by complement C3-dependent adherence to erythrocytes. Neurobiol Aging. 2006;27:1733\u20139.","journal-title":"Neurobiol Aging"},{"key":"916_CR175","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.ajpath.2011.01.006","volume":"178","author":"Y Wang","year":"2011","unstructured":"Wang Y, Hancock AM, Bradner J, Chung KA, Quinn JF, Peskind ER, et al. Complement 3 and factor h in human cerebrospinal fluid in parkinson\u2019s disease, alzheimer\u2019s disease, and multiple-system atrophy. Am J Pathol. 2011;178:1509\u201316.","journal-title":"Am J Pathol"},{"key":"916_CR176","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00702-012-0797-8","volume":"119","author":"J Daborg","year":"2012","unstructured":"Daborg J, Andreasson U, Pekna M, Lautner R, Hanse E, Minthon L, et al. Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in alzheimer\u2019s disease. J Neural Transm (Vienna). 2012;119:789\u201397.","journal-title":"J Neural Transm (Vienna)"},{"key":"916_CR177","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/glia.24355","volume":"71","author":"N Daskoulidou","year":"2023","unstructured":"Daskoulidou N, Shaw B, Torvell M, Watkins L, Cope EL, Carpanini SM, et al. Complement receptor 1 is expressed on brain cells and in the human brain. Glia. 2023;71:1522\u201335.","journal-title":"Glia"},{"key":"916_CR178","doi-asserted-by":"publisher","first-page":"e70458","DOI":"10.1002\/alz.70458","volume":"21","author":"N Daskoulidou","year":"2025","unstructured":"Daskoulidou N, Shaw B, Zelek WM, Morgan BP. The alzheimer\u2019s disease-associated complement receptor 1 variant confers risk by impacting glial phagocytosis. Alzheimers Dement. 2025;21:e70458.","journal-title":"Alzheimers Dement"},{"key":"916_CR179","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.celrep.2019.07.060","volume":"28","author":"T Wu","year":"2019","unstructured":"Wu T, Dejanovic B, Gandham VD, Gogineni A, Edmonds R, Schauer S, et al. Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy. Cell Rep. 2019;28:2111\u2013e236.","journal-title":"Cell Rep"},{"key":"916_CR180","doi-asserted-by":"publisher","first-page":"13460","DOI":"10.1523\/JNEUROSCI.1333-13.2013","volume":"33","author":"AH Stephan","year":"2013","unstructured":"Stephan AH, Madison DV, Mateos JM, Fraser DA, Lovelett EA, Coutellier L, et al. A dramatic increase of C1q protein in the CNS during normal aging. J Neurosci. 2013;33:13460\u201374.","journal-title":"J Neurosci"},{"key":"916_CR181","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.neuron.2018.10.014","volume":"100","author":"B Dejanovic","year":"2018","unstructured":"Dejanovic B, Huntley MA, De Mazi\u00e8re A, Meilandt WJ, Wu T, Srinivasan K, et al. Changes in the synaptic proteome in tauopathy and rescue of Tau-induced synapse loss by C1q antibodies. Neuron. 2018;100:1322\u2013e367.","journal-title":"Neuron"},{"key":"916_CR182","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41591-018-0336-8","volume":"25","author":"C Yin","year":"2019","unstructured":"Yin C, Ackermann S, Ma Z, Mohanta SK, Zhang C, Li Y, et al. ApoE attenuates unresolvable inflammation by complex formation with activated C1q. Nat Med. 2019;25:496\u2013506.","journal-title":"Nat Med"},{"key":"916_CR183","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40478-016-0339-y","volume":"4","author":"LW Bonham","year":"2016","unstructured":"Bonham LW, Desikan RS, Yokoyama JS, Alzheimer\u2019s Disease Neuroimaging Initiative. The relationship between complement factor C3, APOE \u03b54, amyloid and Tau in alzheimer\u2019s disease. Acta Neuropathol Commun. 2016;4:65.","journal-title":"Acta Neuropathol Commun"},{"key":"916_CR184","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1002\/alz.13066","volume":"19","author":"M Chatterjee","year":"2023","unstructured":"Chatterjee M, \u00d6zdemir S, Kunadt M, Koel-Simmelink M, Boiten W, Piepkorn L, et al. C1q is increased in cerebrospinal fluid-derived extracellular vesicles in alzheimer\u2019s disease: A multi-cohort proteomics and immuno-assay validation study. Alzheimers Dement. 2023;19:4828\u201340.","journal-title":"Alzheimers Dement"},{"key":"916_CR185","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-2990.2010.01137.x","volume":"37","author":"J Attems","year":"2011","unstructured":"Attems J, Jellinger K, Thal DR, Van Nostrand W. Review: sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol. 2011;37:75\u201393.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"916_CR186","doi-asserted-by":"publisher","first-page":"7247325","DOI":"10.1155\/2019\/7247325","volume":"2019","author":"J De Reuck","year":"2019","unstructured":"De Reuck J. The impact of cerebral amyloid angiopathy in various neurodegenerative dementia syndromes: A neuropathological study. Neurol Res Int. 2019;2019:7247325.","journal-title":"Neurol Res Int"},{"key":"916_CR187","first-page":"2083","volume":"148","author":"DR Premkumar","year":"1996","unstructured":"Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with alzheimer\u2019s disease. Am J Pathol. 1996;148:2083\u201395.","journal-title":"Am J Pathol"},{"key":"916_CR188","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/jnnp-2011-301308","volume":"83","author":"A Charidimou","year":"2012","unstructured":"Charidimou A, Gang Q, Werring DJ. Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry. 2012;83:124\u201337.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"916_CR189","doi-asserted-by":"publisher","first-page":"216","DOI":"10.5607\/en23014","volume":"32","author":"R Ullah","year":"2023","unstructured":"Ullah R, Lee EJ. Advances in Amyloid-\u03b2 clearance in the brain and periphery: implications for neurodegenerative diseases. Exp Neurobiol. 2023;32:216\u201346.","journal-title":"Exp Neurobiol"},{"issue":"2","key":"916_CR190","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/ana.27253","volume":"98","author":"SS Bruce","year":"2025","unstructured":"Bruce SS, Zhang C, Liberman AL, Merkler AE, Navi BB, Chiang GC, Iadecola C, Kamel H, Murthy SB. Prevalence of cerebral amyloid angiopathy and associated risk of subsequent ischemic and hemorrhagic stroke and mortality in a nationwide cohort. Ann Neurol. 2025;98(2):249\u201357.","journal-title":"Ann Neurol"},{"key":"916_CR191","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1159\/000486091","volume":"44","author":"K Matsuo","year":"2017","unstructured":"Matsuo K, Shindo A, Niwa A, Tabei K-I, Akatsu H, Hashizume Y, et al. Complement activation in capillary cerebral amyloid angiopathy. Dement Geriatr Cogn Disord. 2017;44:343\u201353.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"916_CR192","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-4-22","volume":"4","author":"R Fan","year":"2007","unstructured":"Fan R, DeFilippis K, Van Nostrand WE. Induction of complement proteins in a mouse model for cerebral microvascular A\u03b2 deposition. J Neuroinflamm. 2007;4:1\u20138.","journal-title":"J Neuroinflamm"},{"key":"916_CR193","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s004010050944","volume":"96","author":"MM Verbeek","year":"1998","unstructured":"Verbeek MM, Otte-H\u00f6ller I, Veerhuis R, Ruiter DJ, De Waal RM. Distribution of A beta-associated proteins in cerebrovascular amyloid of alzheimer\u2019s disease. Acta Neuropathol. 1998;96:628\u201336.","journal-title":"Acta Neuropathol"},{"key":"916_CR194","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-018-0540-2","volume":"6","author":"DC Hondius","year":"2018","unstructured":"Hondius DC, Eigenhuis KN, van der Morrema THJ, van Nierop P, Bugiani M, et al. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in alzheimer\u2019s disease. Acta Neuropathol Commun. 2018;6:1\u201319.","journal-title":"Acta Neuropathol Commun"},{"key":"916_CR195","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/nan.12342","volume":"43","author":"A Manousopoulou","year":"2017","unstructured":"Manousopoulou A, Gatherer M, Smith C, Nicoll JAR, Woelk CH, Johnson M, et al. Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy. Neuropathol Appl Neurobiol. 2017;43:492\u2013504.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"916_CR196","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-019-0662-1","volume":"7","author":"Y Endo","year":"2019","unstructured":"Endo Y, Hasegawa K, Nomura R, Arishima H, Kikuta K-I, Yamashita T, et al. Apolipoprotein E and clusterin inhibit the early phase of amyloid-\u03b2 aggregation in an in vitro model of cerebral amyloid angiopathy. Acta Neuropathol Commun. 2019;7:12.","journal-title":"Acta Neuropathol Commun"},{"key":"916_CR197","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40478-021-01303-6","volume":"10","author":"A Zellner","year":"2022","unstructured":"Zellner A, M\u00fcller SA, Lindner B, Beaufort N, Rozemuller AJM, Arzberger T, et al. Proteomic profiling in cerebral amyloid angiopathy reveals an overlap with CADASIL highlighting accumulation of HTRA1 and its substrates. Acta Neuropathol Commun. 2022;10:6.","journal-title":"Acta Neuropathol Commun"},{"key":"916_CR198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-024-02767-1","volume":"148","author":"D Leitner","year":"2024","unstructured":"Leitner D, Kavanagh T, Kanshin E, Balcomb K, Pires G, Thierry M, et al. Differences in the cerebral amyloid angiopathy proteome in alzheimer\u2019s disease and mild cognitive impairment. Acta Neuropathol. 2024;148:1\u201320.","journal-title":"Acta Neuropathol"},{"key":"916_CR199","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s00401-025-02886-3","volume":"149","author":"C Varma","year":"2025","unstructured":"Varma C, Lemere CA. CAA proteomics meta-analysis reveals novel targets, key players, and the effects of sex, APOE, and brain region in humans. Acta Neuropathol. 2025;149:40.","journal-title":"Acta Neuropathol"},{"key":"916_CR200","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, et al. Complement and microglia mediate early synapse loss in alzheimer mouse models. Science. 2016;352:712\u20136.","journal-title":"Science"},{"key":"916_CR201","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1074\/jbc.M112.400168","volume":"288","author":"ME Benoit","year":"2013","unstructured":"Benoit ME, Hernandez MX, Dinh ML, Benavente F, Vasquez O, Tenner AJ. C1q-induced LRP1B and GPR6 proteins expressed early in alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-\u03b2 neurotoxicity. J Biol Chem. 2013;288:654\u201365.","journal-title":"J Biol Chem"},{"key":"916_CR202","doi-asserted-by":"publisher","first-page":"6457","DOI":"10.1523\/JNEUROSCI.0901-04.2004","volume":"24","author":"MI Fonseca","year":"2004","unstructured":"Fonseca MI, Zhou J, Botto M, Tenner AJ. Absence of C1q leads to less neuropathology in Transgenic mouse models of alzheimer\u2019s disease. J Neurosci. 2004;24:6457\u201365.","journal-title":"J Neurosci"},{"key":"916_CR203","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1111\/j.1471-4159.2008.05558.x","volume":"106","author":"J Zhou","year":"2008","unstructured":"Zhou J, Fonseca MI, Pisalyaput K, Tenner AJ. Complement C3 and C4 expression in C1q sufficient and deficient mouse models of alzheimer\u2019s disease. J Neurochem. 2008;106:2080\u201392.","journal-title":"J Neurochem"},{"key":"916_CR204","doi-asserted-by":"crossref","unstructured":"Wang Y, Wu T, Gogineni A, Tsai M-C, Kielpinski L, Mahajan A, et al. Therapeutically targeting the classical complement pathway with antisense oligonucleotides in alzheimer\u2019s disease. BioRxiv. 2024. 2024.08.23.609240.","DOI":"10.1101\/2024.08.23.609240"},{"key":"916_CR205","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12974-017-0814-9","volume":"14","author":"MI Fonseca","year":"2017","unstructured":"Fonseca MI, Chu S-H, Hernandez MX, Fang MJ, Modarresi L, Selvan P, et al. Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain. J Neuroinflammation. 2017;14:48.","journal-title":"J Neuroinflammation"},{"key":"916_CR206","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12974-023-02885-9","volume":"20","author":"TJ Petrisko","year":"2023","unstructured":"Petrisko TJ, Gargus M, Chu S-H, Selvan P, Whiteson KL, Tenner AJ. Influence of complement protein C1q or complement receptor C5aR1 on gut microbiota composition in wildtype and alzheimer\u2019s mouse models. J Neuroinflammation. 2023;20:211.","journal-title":"J Neuroinflammation"},{"key":"916_CR207","doi-asserted-by":"publisher","first-page":"5568","DOI":"10.1007\/s12035-019-1467-8","volume":"56","author":"B Bie","year":"2019","unstructured":"Bie B, Wu J, Foss JF, Naguib M. Activation of mGluR1 mediates C1q-dependent microglial phagocytosis of glutamatergic synapses in alzheimer\u2019s rodent models. Mol Neurobiol. 2019;56:5568\u201385.","journal-title":"Mol Neurobiol"},{"key":"916_CR208","doi-asserted-by":"publisher","first-page":"eabi8593","DOI":"10.1126\/scitranslmed.abi8593","volume":"14","author":"J Spurrier","year":"2022","unstructured":"Spurrier J, Nicholson L, Fang XT, Stoner AJ, Toyonaga T, Holden D, et al. Reversal of synapse loss in alzheimer mouse models by targeting mGluR5 to prevent synaptic tagging by C1Q. Sci Transl Med. 2022;14:eabi8593.","journal-title":"Sci Transl Med"},{"key":"916_CR209","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1007\/s00018-020-03468-0","volume":"77","author":"BA Gy\u00f6rffy","year":"2020","unstructured":"Gy\u00f6rffy BA, T\u00f3th V, T\u00f6r\u00f6k G, Guly\u00e1ssy P, Kov\u00e1cs R\u00c1, Vad\u00e1szi H, et al. Synaptic mitochondrial dysfunction and Septin accumulation are linked to complement-mediated synapse loss in an alzheimer\u2019s disease animal model. Cell Mol Life Sci. 2020;77:5243\u201358.","journal-title":"Cell Mol Life Sci"},{"key":"916_CR210","doi-asserted-by":"publisher","first-page":"816640","DOI":"10.3389\/fimmu.2022.816640","volume":"13","author":"X Hao","year":"2022","unstructured":"Hao X, Li Z, Li W, Katz J, Michalek SM, Barnum SR, et al. Periodontal infection aggravates C1q-mediated microglial activation and synapse pruning in alzheimer\u2019s mice. Front Immunol. 2022;13:816640.","journal-title":"Front Immunol"},{"key":"916_CR211","doi-asserted-by":"publisher","first-page":"eadf0141","DOI":"10.1126\/scitranslmed.adf0141","volume":"15","author":"J Zhou","year":"2023","unstructured":"Zhou J, Wade SD, Graykowski D, Xiao M-F, Zhao B, Giannini LAA, et al. The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration. Sci Transl Med. 2023;15:eadf0141.","journal-title":"Sci Transl Med"},{"key":"916_CR212","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.immuni.2023.06.016","volume":"56","author":"L Zhong","year":"2023","unstructured":"Zhong L, Sheng X, Wang W, Li Y, Zhuo R, Wang K, et al. TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1q during neurodegeneration. Immunity. 2023;56:1794\u2013e8088.","journal-title":"Immunity"},{"key":"916_CR213","doi-asserted-by":"publisher","first-page":"107874","DOI":"10.1016\/j.jbc.2024.107874","volume":"300","author":"D Lin","year":"2024","unstructured":"Lin D, Kaye S, Chen M, Lyanna A, Ye L, Hammond LA, et al. Transcriptome and proteome profiling reveals TREM2-dependent and -independent glial response and metabolic perturbation in an alzheimer\u2019s mouse model. J Biol Chem. 2024;300:107874.","journal-title":"J Biol Chem"},{"key":"916_CR214","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41380-018-0255-6","volume":"24","author":"J-V Haure-Mirande","year":"2019","unstructured":"Haure-Mirande J-V, Wang M, Audrain M, Fanutza T, Kim SH, Heja S, et al. Integrative approach to sporadic alzheimer\u2019s disease: deficiency of TYROBP in cerebral A\u03b2 amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing A\u03b2 burden. Mol Psychiatry. 2019;24:431\u201346.","journal-title":"Mol Psychiatry"},{"key":"916_CR215","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/s41380-018-0258-3","volume":"24","author":"M Audrain","year":"2019","unstructured":"Audrain M, Haure-Mirande J-V, Wang M, Kim SH, Fanutza T, Chakrabarty P, et al. Integrative approach to sporadic alzheimer\u2019s disease: deficiency of TYROBP in a Tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of Tau. Mol Psychiatry. 2019;24:1383\u201397.","journal-title":"Mol Psychiatry"},{"key":"916_CR216","doi-asserted-by":"publisher","first-page":"122457","DOI":"10.1016\/j.lfs.2024.122457","volume":"340","author":"C Zhang","year":"2024","unstructured":"Zhang C, Qi H, Jia D, Zhao J, Xu C, Liu J, et al. Cognitive impairment in alzheimer\u2019s disease FAD4T mouse model: synaptic loss facilitated by activated microglia via C1qA. Life Sci. 2024;340:122457.","journal-title":"Life Sci"},{"key":"916_CR217","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13024-024-00789-7","volume":"19","author":"L Zhang","year":"2024","unstructured":"Zhang L, Huang L, Zhou Y, Meng J, Zhang L, Zhou Y, et al. Microglial CD2AP deficiency exerts protection in an alzheimer\u2019s disease model of amyloidosis. Mol Neurodegener. 2024;19:95.","journal-title":"Mol Neurodegener"},{"key":"916_CR218","doi-asserted-by":"crossref","unstructured":"Li S, Li M, Li G, Li L, Yang X, Zuo Z et al. Physical exercise decreases complement-mediated synaptic loss and protects against cognitive impairment by inhibiting microglial Tmem9-ATP6V0D1 in alzheimer\u2019s disease. Aging Cell. 2025;e14496.","DOI":"10.1111\/acel.14496"},{"key":"916_CR219","doi-asserted-by":"publisher","first-page":"13029","DOI":"10.1523\/JNEUROSCI.1698-15.2015","volume":"35","author":"Q Shi","year":"2015","unstructured":"Shi Q, Colodner KJ, Matousek SB, Merry K, Hong S, Kenison JE, et al. Complement C3-deficient mice fail to display age-related hippocampal decline. J Neurosci. 2015;35:13029\u201342.","journal-title":"J Neurosci"},{"issue":"392","key":"916_CR220","doi-asserted-by":"publisher","first-page":"eaaf6295","DOI":"10.1126\/scitranslmed.aaf6295","volume":"9","author":"Q Shi","year":"2017","unstructured":"Shi Q, Chowdhury S, Ma R, Le KX, Hong S, Caldarone BJ, Stevens B, Lemere CA. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP\/PS1 mice. Sci Transl Med. 2017;9(392):eaaf6295.","journal-title":"Sci Transl Med"},{"key":"916_CR221","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40478-022-01404-w","volume":"10","author":"SM Carpanini","year":"2022","unstructured":"Carpanini SM, Torvell M, Bevan RJ, Byrne RAJ, Daskoulidou N, Saito T, et al. Terminal complement pathway activation drives synaptic loss in alzheimer\u2019s disease models. Acta Neuropathol Commun. 2022;10:99.","journal-title":"Acta Neuropathol Commun"},{"key":"916_CR222","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.neuron.2018.10.031","volume":"100","author":"A Litvinchuk","year":"2018","unstructured":"Litvinchuk A, Wan Y-W, Swartzlander DB, Chen F, Cole A, Propson NE, et al. Complement C3aR inactivation attenuates Tau pathology and reverses an immune network deregulated in Tauopathy models and alzheimer\u2019s disease. Neuron. 2018;100:1337\u2013e535.","journal-title":"Neuron"},{"issue":"12","key":"916_CR223","doi-asserted-by":"publisher","first-page":"e167501","DOI":"10.1172\/JCI167501","volume":"133","author":"M Gedam","year":"2023","unstructured":"Gedam M, Comerota MM, Propson NE, Chen T, Jin F, Wang MC, Zheng H. Complement C3aR depletion reverses HIF-1\u03b1-induced metabolic impairment and enhances microglial response to A\u03b2 pathology. J Clin Invest. 2023;133(12):e167501.","journal-title":"J Clin Invest"},{"key":"916_CR224","doi-asserted-by":"crossref","unstructured":"Wang Y, Pandey S, Weber M, Choy MK, Wu T, Chernov-Rogan T, et al. Complement C3aR deletion does not attenuate neurodegeneration in a tauopathy model or alter acute inflammation-induced gene expression changes in the brain. bioRxiv. 2025. p. 2025.06.16.660026.","DOI":"10.1101\/2025.06.16.660026"},{"issue":"1","key":"916_CR225","doi-asserted-by":"publisher","first-page":"e140966","DOI":"10.1172\/JCI140966","volume":"131","author":"NE Propson","year":"2021","unstructured":"Propson NE, Roy ER, Litvinchuk A, K\u00f6hl J, Zheng H. Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging. J Clin Invest. 2021;131(1):e140966.","journal-title":"J Clin Invest"},{"key":"916_CR226","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s12975-022-00993-x","volume":"13","author":"K Bhatia","year":"2022","unstructured":"Bhatia K, Kindelin A, Nadeem M, Khan MB, Yin J, Fuentes A, et al. Complement C3a receptor (C3aR) mediates vascular dysfunction, hippocampal pathology, and cognitive impairment in a mouse model of VCID. Transl Stroke Res. 2022;13:816\u201329.","journal-title":"Transl Stroke Res"},{"key":"916_CR227","doi-asserted-by":"publisher","first-page":"110685","DOI":"10.1016\/j.brainresbull.2023.110685","volume":"200","author":"Y Yao","year":"2023","unstructured":"Yao Y, Chang Y, Li S, Zhu J, Wu Y, Jiang X, et al. Complement C3a receptor antagonist alleviates Tau pathology and ameliorates cognitive deficits in P301S mice. Brain Res Bull. 2023;200:110685.","journal-title":"Brain Res Bull"},{"key":"916_CR228","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fimmu.2015.00220","volume":"6","author":"TM Woodruff","year":"2015","unstructured":"Woodruff TM, Tenner AJ. A commentary on: NF\u03baB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with alzheimer\u2019s disease. A cautionary note regarding C3aR. Front Immunol. 2015;6:220.","journal-title":"Front Immunol"},{"key":"916_CR229","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.1111\/bph.15264","volume":"177","author":"JD Lee","year":"2020","unstructured":"Lee JD, Taylor SM, Woodruff TM. Is the C3a receptor antagonist SB290157 a useful Pharmacological tool? Br J Pharmacol. 2020;177:5677\u20138.","journal-title":"Br J Pharmacol"},{"key":"916_CR230","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/1742-2094-9-220","volume":"9","author":"M Britschgi","year":"2012","unstructured":"Britschgi M, Takeda-Uchimura Y, Rockenstein E, Johns H, Masliah E, Wyss-Coray T. Deficiency of terminal complement pathway inhibitor promotes neuronal Tau pathology and degeneration in mice. J Neuroinflammation. 2012;9:220.","journal-title":"J Neuroinflammation"},{"key":"916_CR231","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.4103\/1673-5374.332160","volume":"17","author":"X-C Zhu","year":"2022","unstructured":"Zhu X-C, Liu L, Dai W-Z, Ma T. Crry Silencing alleviates alzheimer\u2019s disease injury by regulating neuroinflammatory cytokines and the complement system. Neural Regen Res. 2022;17:1841\u20139.","journal-title":"Neural Regen Res"},{"key":"916_CR232","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.3390\/ijms25042272","volume":"25","author":"I Hasantari","year":"2024","unstructured":"Hasantari I, Nicolas N, Alzieu P, Leval L, Shalabi A, Grolleau S, et al. Factor h\u2019s control of complement activation emerges as a significant and promising therapeutic target for alzheimer\u2019s disease treatment. Int J Mol Sci. 2024;25:2272.","journal-title":"Int J Mol Sci"},{"key":"916_CR233","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1038\/s41467-021-22301-1","volume":"12","author":"X Ding","year":"2021","unstructured":"Ding X, Wang J, Huang M, Chen Z, Liu J, Zhang Q, et al. Loss of microglial SIRP\u03b1 promotes synaptic pruning in preclinical models of neurodegeneration. Nat Commun. 2021;12:2030.","journal-title":"Nat Commun"},{"key":"916_CR234","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.neuron.2019.01.014","volume":"101","author":"M Merlini","year":"2019","unstructured":"Merlini M, Rafalski VA, Rios Coronado PE, Gill TM, Ellisman M, Muthukumar G, et al. Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an alzheimer\u2019s disease model. Neuron. 2019;101:1099\u2013e1086.","journal-title":"Neuron"},{"key":"916_CR235","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neuroscience.2019.07.050","volume":"416","author":"X Shi","year":"2019","unstructured":"Shi X, Ohta Y, Liu X, Shang J, Morihara R, Nakano Y, et al. Chronic cerebral hypoperfusion activates the coagulation and complement cascades in alzheimer\u2019s disease mice. Neuroscience. 2019;416:126\u201336.","journal-title":"Neuroscience"},{"key":"916_CR236","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1111\/febs.17150","volume":"291","author":"CJ Yoo","year":"2024","unstructured":"Yoo CJ, Choi Y, Bok E, Lin Y, Cheon M, Lee Y-H, et al. Complement receptor 4 mediates the clearance of extracellular Tau fibrils by microglia. FEBS J. 2024;291:3499\u2013520.","journal-title":"FEBS J"},{"key":"916_CR237","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.4049\/jimmunol.0901005","volume":"183","author":"MI Fonseca","year":"2009","unstructured":"Fonseca MI, Ager RR, Chu S-H, Yazan O, Sanderson SD, LaFerla FM, et al. Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of alzheimer\u2019s disease. J Immunol. 2009;183:1375\u201383.","journal-title":"J Immunol"},{"key":"916_CR238","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12974-015-0369-6","volume":"12","author":"C Landlinger","year":"2015","unstructured":"Landlinger C, Oberleitner L, Gruber P, Noiges B, Yatsyk K, Santic R, et al. Active immunization against complement factor C5a: a new therapeutic approach for alzheimer\u2019s disease. J Neuroinflammation. 2015;12:150.","journal-title":"J Neuroinflammation"},{"key":"916_CR239","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1021\/acsinfecdis.0c00005","volume":"6","author":"AM Alshammari","year":"2020","unstructured":"Alshammari AM, Smith DD, Parriott J, Stewart JP, Curran SM, McCulloh RJ, et al. Targeted amino acid substitution overcomes scale-up challenges with the human C5a-derived decapeptide immunostimulant EP67. ACS Infect Dis. 2020;6:1169\u201381.","journal-title":"ACS Infect Dis"},{"key":"916_CR240","doi-asserted-by":"publisher","first-page":"e0225417","DOI":"10.1371\/journal.pone.0225417","volume":"14","author":"E Panayiotou","year":"2019","unstructured":"Panayiotou E, Fella E, Andreou S, Papacharalambous R, Gerasimou P, Costeas P, et al. C5aR agonist enhances phagocytosis of fibrillar and non-fibrillar A\u03b2 amyloid and preserves memory in a mouse model of Familial alzheimer\u2019s disease. PLoS ONE. 2019;14:e0225417.","journal-title":"PLoS ONE"},{"key":"916_CR241","doi-asserted-by":"publisher","first-page":"108074","DOI":"10.1016\/j.intimp.2021.108074","volume":"100","author":"XX Li","year":"2021","unstructured":"Li XX, Clark RJ, Woodruff TM. Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists. Int Immunopharmacol. 2021;100:108074.","journal-title":"Int Immunopharmacol"},{"key":"916_CR242","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/S1567-5769(01)00141-2","volume":"1","author":"SM Vogen","year":"2001","unstructured":"Vogen SM, Paczkowski NJ, Kirnarsky L, Short A, Whitmore JB, Sherman SA, et al. Differential activities of decapeptide agonists of human C5a: the conformational effects of backbone N-methylation. Int Immunopharmacol. 2001;1:2151\u201362.","journal-title":"Int Immunopharmacol"},{"key":"916_CR243","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12974-022-02539-2","volume":"19","author":"K Carvalho","year":"2022","unstructured":"Carvalho K, Schartz ND, Balderrama-Gutierrez G, Liang HY, Chu S-H, Selvan P, et al. Modulation of C5a-C5aR1 signaling alters the dynamics of AD progression. J Neuroinflammation. 2022;19:178.","journal-title":"J Neuroinflammation"},{"key":"916_CR244","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s40478-022-01416-6","volume":"10","author":"A Gomez-Arboledas","year":"2022","unstructured":"Gomez-Arboledas A, Carvalho K, Balderrama-Gutierrez G, Chu S-H, Liang HY, Schartz ND, et al. C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of alzheimer\u2019s disease. Acta Neuropathol Commun. 2022;10:116.","journal-title":"Acta Neuropathol Commun"},{"key":"916_CR245","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/alz.13682","volume":"20","author":"A Gomez-Arboledas","year":"2024","unstructured":"Gomez-Arboledas A, Fonseca MI, Kramar E, Chu S-H, Schartz ND, Selvan P, et al. C5aR1 signaling promotes region- and age-dependent synaptic pruning in models of alzheimer\u2019s disease. Alzheimers Dement. 2024;20:2173\u201390.","journal-title":"Alzheimers Dement"},{"key":"916_CR246","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.bbi.2024.03.017","volume":"118","author":"WM Zelek","year":"2024","unstructured":"Zelek WM, Bevan RJ, Morgan BP. Targeting terminal pathway reduces brain complement activation, amyloid load and synapse loss, and improves cognition in a mouse model of dementia. Brain Behav Immun. 2024;118:355\u201363.","journal-title":"Brain Behav Immun"},{"key":"916_CR247","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/brain\/awae278","volume":"148","author":"WM Zelek","year":"2025","unstructured":"Zelek WM, Bevan RJ, Nimmo J, Dewilde M, De Strooper B, Morgan BP. Brain-penetrant complement Inhibition mitigates neurodegeneration in an alzheimer\u2019s disease mouse model. Brain. 2025;148:941\u201354.","journal-title":"Brain"},{"key":"916_CR248","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1038\/s41467-023-39693-x","volume":"14","author":"M Hu","year":"2023","unstructured":"Hu M, Li T, Ma X, Liu S, Li C, Huang Z, et al. Macrophage lineage cells-derived migrasomes activate complement-dependent blood-brain barrier damage in cerebral amyloid angiopathy mouse model. Nat Commun. 2023;14:3945.","journal-title":"Nat Commun"},{"key":"916_CR249","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.cell.2020.06.038","volume":"182","author":"W-T Chen","year":"2020","unstructured":"Chen W-T, Lu A, Craessaerts K, Pavie B, Sala Frigerio C, Corthout N, et al. Spatial transcriptomics and in situ sequencing to study alzheimer\u2019s disease. Cell. 2020;182:976\u2013e9119.","journal-title":"Cell"},{"key":"916_CR250","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1742-2094-8-4","volume":"8","author":"MI Fonseca","year":"2011","unstructured":"Fonseca MI, Chu S-H, Berci AM, Benoit ME, Peters DG, Kimura Y, et al. Contribution of complement activation pathways to neuropathology differs among mouse models of alzheimer\u2019s disease. J Neuroinflammation. 2011;8:4.","journal-title":"J Neuroinflammation"},{"key":"916_CR251","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.1523\/JNEUROSCI.0829-08.2008","volume":"28","author":"M Maier","year":"2008","unstructured":"Maier M, Peng Y, Jiang L, Seabrook TJ, Carroll MC, Lemere CA. Complement C3 deficiency leads to accelerated amyloid plaque deposition and neurodegeneration and modulation of the microglia\/macrophage phenotype in amyloid precursor protein Transgenic mice. J Neurosci. 2008;28:6333\u201341.","journal-title":"J Neurosci"},{"key":"916_CR252","doi-asserted-by":"crossref","unstructured":"Zhuang B, Mancarci BO, Toker L, Pavlidis P. Mega-analysis of gene expression in mouse models of Alzheimer\u2019s disease. eNeuro. 2019;6:ENEURO.0226\u201319.2019.","DOI":"10.1523\/ENEURO.0226-19.2019"},{"key":"916_CR253","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1021\/acs.jproteome.0c00255","volume":"19","author":"X Zhang","year":"2020","unstructured":"Zhang X, Liu W, Cao Y, Tan W. Hippocampus proteomics and brain lipidomics reveal network dysfunction and lipid molecular abnormalities in APP\/PS1 mouse model of alzheimer\u2019s disease. J Proteome Res. 2020;19:3427\u201337.","journal-title":"J Proteome Res"},{"key":"916_CR254","doi-asserted-by":"publisher","first-page":"727784","DOI":"10.3389\/fnins.2021.727784","volume":"15","author":"MJ Lee","year":"2021","unstructured":"Lee MJ, Wang C, Carroll MJ, Brubaker DK, Hyman BT, Lauffenburger DA. Computational interspecies translation between alzheimer\u2019s disease mouse models and human subjects identifies innate immune complement, TYROBP, and TAM receptor agonist signatures, distinct from influences of aging. Front Neurosci. 2021;15:727784.","journal-title":"Front Neurosci"},{"key":"916_CR255","doi-asserted-by":"publisher","first-page":"5460","DOI":"10.1002\/alz.14038","volume":"20","author":"C Varma","year":"2024","unstructured":"Varma C, Luo E, Bostrom G, Bathini P, Berdnik D, Wyss-Coray T, et al. Plasma and CSF biomarkers of aging and cognitive decline in Caribbean vervets. Alzheimers Dement. 2024;20:5460\u201380.","journal-title":"Alzheimers Dement"},{"key":"916_CR256","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481\u20137.","journal-title":"Nature"},{"key":"916_CR257","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuron.2014.11.018","volume":"85","author":"H Lian","year":"2015","unstructured":"Lian H, Yang L, Cole A, Sun L, Chiang AC-A, Fowler SW, et al. NF\u03baB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with alzheimer\u2019s disease. Neuron. 2015;85:101\u201315.","journal-title":"Neuron"},{"key":"916_CR258","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1523\/JNEUROSCI.2117-15.2016","volume":"36","author":"H Lian","year":"2016","unstructured":"Lian H, Litvinchuk A, Chiang AC-A, Aithmitti N, Jankowsky JL, Zheng H. Astrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of alzheimer\u2019s disease. J Neurosci. 2016;36:577\u201389.","journal-title":"J Neurosci"},{"key":"916_CR259","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41593-020-00796-z","volume":"24","author":"SR Guttikonda","year":"2021","unstructured":"Guttikonda SR, Sikkema L, Tchieu J, Saurat N, Walsh RM, Harschnitz O, et al. Fully defined human pluripotent stem cell-derived microglia and tri-culture system model C3 production in alzheimer\u2019s disease. Nat Neurosci. 2021;24:343\u201354.","journal-title":"Nat Neurosci"},{"key":"916_CR260","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.nbd.2016.08.001","volume":"96","author":"T Iram","year":"2016","unstructured":"Iram T, Trudler D, Kain D, Kanner S, Galron R, Vassar R, et al. Astrocytes from old alzheimer\u2019s disease mice are impaired in A\u03b2 uptake and in neuroprotection. Neurobiol Dis. 2016;96:84\u201394.","journal-title":"Neurobiol Dis"},{"key":"916_CR261","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41593-023-01257-z","volume":"26","author":"S De Schepper","year":"2023","unstructured":"De Schepper S, Ge JZ, Crowley G, Ferreira LSS, Garceau D, Toomey CE, et al. Perivascular cells induce microglial phagocytic States and synaptic engulfment via SPP1 in mouse models of alzheimer\u2019s disease. Nat Neurosci. 2023;26:406\u201315.","journal-title":"Nat Neurosci"},{"key":"916_CR262","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.neuron.2017.03.042","volume":"94","author":"EM Abud","year":"2017","unstructured":"Abud EM, Ramirez RN, Martinez ES, Healy LM, Nguyen CHH, Newman SA, et al. IPSC-derived human microglia-like cells to study neurological diseases. Neuron. 2017;94:278\u2013e939.","journal-title":"Neuron"},{"key":"916_CR263","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/glia.24485","volume":"72","author":"J Penney","year":"2024","unstructured":"Penney J, Ralvenius WT, Loon A, Cerit O, Dileep V, Milo B, et al. iPSC-derived microglia carrying the TREM2 R47H\/+ mutation are Proinflammatory and promote synapse loss. Glia. 2024;72:452\u201369.","journal-title":"Glia"},{"key":"916_CR264","doi-asserted-by":"publisher","first-page":"617860","DOI":"10.3389\/fimmu.2020.617860","volume":"11","author":"M Reich","year":"2020","unstructured":"Reich M, Paris I, Ebeling M, Dahm N, Schweitzer C, Reinhardt D, et al. Alzheimer\u2019s risk gene TREM2 determines functional properties of new type of human iPSC-derived microglia. Front Immunol. 2020;11:617860.","journal-title":"Front Immunol"},{"key":"916_CR265","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.stemcr.2024.07.002","volume":"19","author":"C Gomes","year":"2024","unstructured":"Gomes C, Huang K-C, Harkin J, Baker A, Hughes JM, Pan Y, et al. Induction of astrocyte reactivity promotes neurodegeneration in human pluripotent stem cell models. Stem Cell Rep. 2024;19:1122\u201336.","journal-title":"Stem Cell Rep"},{"key":"916_CR266","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41593-022-01131-4","volume":"25","author":"NM Dr\u00e4ger","year":"2022","unstructured":"Dr\u00e4ger NM, Sattler SM, Huang CT-L, Teter OM, Leng K, Hashemi SH, et al. A CRISPRi\/a platform in human iPSC-derived microglia uncovers regulators of disease States. Nat Neurosci. 2022;25:1149\u201362.","journal-title":"Nat Neurosci"},{"key":"916_CR267","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jim.2018.02.004","volume":"456","author":"AJF Thielen","year":"2018","unstructured":"Thielen AJF, van Baarsen IM, Jongsma ML, Zeerleder S, Spaapen RM, Wouters D. CRISPR\/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research. J Immunol Methods. 2018;456:15\u201322.","journal-title":"J Immunol Methods"},{"key":"916_CR268","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13287-024-03876-0","volume":"15","author":"TJ Wenzel","year":"2024","unstructured":"Wenzel TJ, Desjarlais JD, Mousseau DD. Human brain organoids containing microglia that have arisen innately adapt to a \u03b2-amyloid challenge better than those in which microglia are integrated by co-culture. Stem Cell Res Ther. 2024;15:258.","journal-title":"Stem Cell Res Ther"},{"key":"916_CR269","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s42003-024-07401-0","volume":"8","author":"X Chen","year":"2025","unstructured":"Chen X, Sun G, Feng L, Tian E, Shi Y. Human iPSC-derived microglial cells protect neurons from neurodegeneration in long-term cultured adhesion brain organoids. Commun Biol. 2025;8:30.","journal-title":"Commun Biol"},{"key":"916_CR270","doi-asserted-by":"publisher","first-page":"1419526","DOI":"10.3389\/fncel.2024.1419526","volume":"18","author":"N Urrestizala-Arenaza","year":"2024","unstructured":"Urrestizala-Arenaza N, Cerchio S, Cavaliere F, Magliaro C. Limitations of human brain organoids to study neurodegenerative diseases: a manual to survive. Front Cell Neurosci. 2024;18:1419526.","journal-title":"Front Cell Neurosci"},{"key":"916_CR271","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature25032","volume":"553","author":"SP Pa\u0219ca","year":"2018","unstructured":"Pa\u0219ca SP. The rise of three-dimensional human brain cultures. Nature. 2018;553:437\u201345.","journal-title":"Nature"},{"key":"916_CR272","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-1-0716-1601-7_6","volume":"2352","author":"L Zhou-Yang","year":"2021","unstructured":"Zhou-Yang L, Eichhorner S, Karbacher L, B\u00f6hnke L, Traxler L, Mertens J. Direct conversion of human fibroblasts to induced neurons. Methods Mol Biol. 2021;2352:73\u201396.","journal-title":"Methods Mol Biol"},{"key":"916_CR273","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41467-022-28043-y","volume":"13","author":"B Cakir","year":"2022","unstructured":"Cakir B, Tanaka Y, Kiral FR, Xiang Y, Dagliyan O, Wang J, et al. Expression of the transcription factor PU.1 induces the generation of microglia-like cells in human cortical organoids. Nat Commun. 2022;13:430.","journal-title":"Nat Commun"},{"key":"916_CR274","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, et al. Single-cell transcriptomic analysis of alzheimer\u2019s disease. Nature. 2019;570:332\u20137.","journal-title":"Nature"},{"key":"916_CR275","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.smim.2018.05.002","volume":"37","author":"C Kemper","year":"2018","unstructured":"Kemper C, K\u00f6hl J. Back to the future - non-canonical functions of complement. Semin Immunol. 2018;37:1\u20133.","journal-title":"Semin Immunol"},{"key":"916_CR276","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.4049\/jimmunol.1700393","volume":"198","author":"S Denk","year":"2017","unstructured":"Denk S, Neher MD, Messerer DAC, Wiegner R, Nilsson B, Rittirsch D, et al. Complement C5a functions as a master switch for the pH balance in neutrophils exerting fundamental immunometabolic effects. J Immunol. 2017;198:4846\u201354.","journal-title":"J Immunol"},{"key":"916_CR277","doi-asserted-by":"publisher","first-page":"aad1210","DOI":"10.1126\/science.aad1210","volume":"352","author":"G Arbore","year":"2016","unstructured":"Arbore G, West EE, Spolski R, Robertson AAB, Klos A, Rheinheimer C, et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells. Science. 2016;352:aad1210.","journal-title":"Science"},{"key":"916_CR278","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41569-024-01016-y","volume":"21","author":"P Maffia","year":"2024","unstructured":"Maffia P, Mauro C, Case A, Kemper C. Canonical and non-canonical roles of complement in atherosclerosis. Nat Rev Cardiol. 2024;21:743\u201361.","journal-title":"Nat Rev Cardiol"},{"key":"916_CR279","doi-asserted-by":"crossref","unstructured":"de Oliveira-Tore F, de Moraes C, Pl\u00e1cido AG, Signorini HMBS, Fontana NMDL, Batista Godoy PD, et al. Non-canonical extracellular complement pathways and the complosome paradigm in cancer: a scoping review. Front Immunol. 2025;16:1519465.","DOI":"10.3389\/fimmu.2025.1519465"},{"key":"916_CR280","doi-asserted-by":"publisher","first-page":"820","DOI":"10.2174\/011570159X327960240823065729","volume":"23","author":"A Pittaluga","year":"2025","unstructured":"Pittaluga A, Torre V, Olivero G, Rosenwasser N, Taddeucci A. Non-canonical roles of complement in the CNS: from synaptic organizer to presynaptic modulator of glutamate transmission. Curr Neuropharmacol. 2025;23:820\u201334.","journal-title":"Curr Neuropharmacol"},{"key":"916_CR281","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.it.2024.09.006","volume":"45","author":"EE West","year":"2024","unstructured":"West EE, Kemper C. Intracellular C1q - an unexpected player in neuronal proteostasis. Trends Immunol. 2024;45:718\u201320.","journal-title":"Trends Immunol"},{"key":"916_CR282","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA. Effects of age, sex, and ethnicity on the association between Apolipoprotein E genotype and alzheimer disease: A meta-analysis. JAMA. 1997;278:1349.","journal-title":"JAMA"},{"key":"916_CR283","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.gde.2011.02.002","volume":"21","author":"J-C Lambert","year":"2011","unstructured":"Lambert J-C, Amouyel P. Genetics of alzheimer\u2019s disease: new evidences for an old hypothesis? Curr Opin Genet Dev. 2011;21:295\u2013301.","journal-title":"Curr Opin Genet Dev"},{"key":"916_CR284","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1001\/archneurol.2007.3","volume":"65","author":"H Li","year":"2008","unstructured":"Li H, Wetten S, Li L, St Jean PL, Upmanyu R, Surh L, et al. Candidate single-nucleotide polymorphisms from a genomewide association study of alzheimer disease. Arch Neurol. 2008;65:45\u201353.","journal-title":"Arch Neurol"},{"key":"916_CR285","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.neuron.2007.05.022","volume":"54","author":"EM Reiman","year":"2007","unstructured":"Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, et al. GAB2 alleles modify alzheimer\u2019s risk in APOE \u025b4 carriers. Neuron. 2007;54:713\u201320.","journal-title":"Neuron"},{"key":"916_CR286","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1755-8794-1-44","volume":"1","author":"R Abraham","year":"2008","unstructured":"Abraham R, Moskvina V, Sims R, Hollingworth P, Morgan A, Georgieva L, et al. A genome-wide association study for late-onset alzheimer\u2019s disease using DNA pooling. BMC Med Genomics. 2008;1:44.","journal-title":"BMC Med Genomics"},{"key":"916_CR287","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","volume":"83","author":"L Bertram","year":"2008","unstructured":"Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan MF, et al. Genome-wide association analysis reveals putative alzheimer\u2019s disease susceptibility loci in addition to APOE. Am J Hum Genet. 2008;83:623\u201332.","journal-title":"Am J Hum Genet"},{"key":"916_CR288","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/ng.305","volume":"41","author":"MM Carrasquillo","year":"2009","unstructured":"Carrasquillo MM, Zou F, Pankratz VS, Wilcox SL, Ma L, Walker LP, et al. Genetic variation in PCDH11X is associated with susceptibility to late-onset alzheimer\u2019s disease. Nat Genet. 2009;41:192\u20138.","journal-title":"Nat Genet"},{"key":"916_CR289","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ajhg.2008.12.008","volume":"84","author":"GW Beecham","year":"2009","unstructured":"Beecham GW, Martin ER, Li Y-J, Slifer MA, Gilbert JR, Haines JL, et al. Genome-wide association study implicates a chromosome 12 risk locus for late-onset alzheimer disease. Am J Hum Genet. 2009;84:35\u201343.","journal-title":"Am J Hum Genet"},{"key":"916_CR290","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrneurol.2009.213","volume":"6","author":"L Bertram","year":"2010","unstructured":"Bertram L, Tanzi RE. Alzheimer disease: new light on an old CLU: alzheimer disease. Nat Rev Neurol. 2010;6:11\u20133.","journal-title":"Nat Rev Neurol"},{"key":"916_CR291","doi-asserted-by":"publisher","first-page":"5380","DOI":"10.1021\/bi00474a025","volume":"29","author":"HV de Silva","year":"1990","unstructured":"de Silva HV, Harmony JA, Stuart WD, Gil CM, Robbins J. Apolipoprotein J: structure and tissue distribution. Biochemistry. 1990;29:5380\u20139.","journal-title":"Biochemistry"},{"key":"916_CR292","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0896-6273(03)00850-X","volume":"41","author":"RB DeMattos","year":"2004","unstructured":"DeMattos RB, Cirrito JR, Parsadanian M, May PC, O\u2019Dell MA, Taylor JW, et al. ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron. 2004;41:193\u2013202.","journal-title":"Neuron"},{"key":"916_CR293","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S1357-2725(01)00155-8","volume":"34","author":"SE Jones","year":"2002","unstructured":"Jones SE, Jomary C, Clusterin. Int J Biochem Cell Biol. 2002;34:427\u201331.","journal-title":"Int J Biochem Cell Biol"},{"key":"916_CR294","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.brainresrev.2009.05.007","volume":"61","author":"T Nuutinen","year":"2009","unstructured":"Nuutinen T, Suuronen T, Kauppinen A, Salminen A. Clusterin: a forgotten player in alzheimer\u2019s disease. Brain Res Rev. 2009;61:89\u2013104.","journal-title":"Brain Res Rev"},{"key":"916_CR295","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13024-020-00416-1","volume":"15","author":"AM Wojtas","year":"2020","unstructured":"Wojtas AM, Sens JP, Kang SS, Baker KE, Berry TJ, Kurti A, et al. Astrocyte-derived clusterin suppresses amyloid formation in vivo. Mol Neurodegener. 2020;15:71.","journal-title":"Mol Neurodegener"},{"key":"916_CR296","doi-asserted-by":"crossref","unstructured":"Lish AM, Grogan EFL, Benoit CR, Pearse RV 2nd, Heuer SE, Luquez T, et al. CLU alleviates alzheimer\u2019s disease-relevant processes by modulating astrocyte reactivity and microglia-dependent synaptic density. Neuron. 2025;113(12):1925\u2013e194611.","DOI":"10.1016\/j.neuron.2025.03.034"},{"key":"916_CR297","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1038\/s41467-021-25060-1","volume":"12","author":"P Yuste-Checa","year":"2021","unstructured":"Yuste-Checa P, Trinkaus VA, Riera-Tur I, Imamoglu R, Schaller TF, Wang H, et al. The extracellular chaperone clusterin enhances Tau aggregate seeding in a cellular model. Nat Commun. 2021;12:4863.","journal-title":"Nat Commun"},{"key":"916_CR298","doi-asserted-by":"publisher","first-page":"10843","DOI":"10.1073\/pnas.162228299","volume":"99","author":"RB DeMattos","year":"2002","unstructured":"DeMattos RB, O\u2019dell MA, Parsadanian M, Taylor JW, Harmony JAK, Bales KR, et al. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2002;99:10843\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"916_CR299","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1096\/fj.06-7986com","volume":"21","author":"JJ Yerbury","year":"2007","unstructured":"Yerbury JJ, Poon S, Meehan S, Thompson B, Kumita JR, Dobson CM, et al. The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J. 2007;21:2312\u201322.","journal-title":"FASEB J"},{"key":"916_CR300","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1038\/tp.2011.17","volume":"1","author":"M Szymanski","year":"2011","unstructured":"Szymanski M, Wang R, Bassett SS, Avramopoulos D. Alzheimer\u2019s risk variants in the clusterin gene are associated with alternative splicing. Transl Psychiatry. 2011;1:e18\u201318.","journal-title":"Transl Psychiatry"},{"key":"916_CR301","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1212\/WNL.0b013e3182605801","volume":"79","author":"M Allen","year":"2012","unstructured":"Allen M, Zou F, Chai HS, Younkin CS, Crook J, Pankratz VS, et al. Novel late-onset alzheimer disease loci variants associate with brain gene expression. Neurology. 2012;79:221\u20138.","journal-title":"Neurology"},{"key":"916_CR302","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1016\/j.jalz.2011.05.2412","volume":"7","author":"C Ant\u00fanez","year":"2011","unstructured":"Ant\u00fanez C, Boada M, L\u00f3pez-Arrieta J, Moreno-Rey C, Hern\u00e1ndez I, Mar\u00edn J, et al. Genetic association of complement receptor 1 polymorphism rs3818361 in alzheimer\u2019s disease. Alzheimers Dement. 2011;7:e124\u20139.","journal-title":"Alzheimers Dement"},{"key":"916_CR303","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1007\/s12035-015-9343-7","volume":"53","author":"Y Li","year":"2016","unstructured":"Li Y, Song D, Jiang Y, Wang J, Feng R, Zhang L, et al. CR1 rs3818361 polymorphism contributes to alzheimer\u2019s disease susceptibility in Chinese population. Mol Neurobiol. 2016;53:4054\u20139.","journal-title":"Mol Neurobiol"},{"key":"916_CR304","doi-asserted-by":"publisher","first-page":"e22351","DOI":"10.1016\/j.neurobiolaging.2013.03.008","volume":"34","author":"C Van Cauwenberghe","year":"2013","unstructured":"Van Cauwenberghe C, Bettens K, Engelborghs S, Vandenbulcke M, Van Dongen J, Vermeulen S, et al. Complement receptor 1 coding variant p.Ser1610Thr in alzheimer\u2019s disease and related endophenotypes. Neurobiol Aging. 2013;34:e22351\u20136.","journal-title":"Neurobiol Aging"},{"key":"916_CR305","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s12035-014-8761-2","volume":"51","author":"N Shen","year":"2015","unstructured":"Shen N, Chen B, Jiang Y, Feng R, Liao M, Zhang L, et al. An updated analysis with 85,939 samples confirms the association between CR1 rs6656401 polymorphism and alzheimer\u2019s disease. Mol Neurobiol. 2015;51:1017\u201323.","journal-title":"Mol Neurobiol"},{"key":"916_CR306","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neulet.2012.08.032","volume":"527","author":"C Jin","year":"2012","unstructured":"Jin C, Li W, Yuan J, Xu W, Cheng Z. Association of the CR1 polymorphism with late-onset alzheimer\u2019s disease in Chinese Han populations: a meta-analysis. Neurosci Lett. 2012;527:46\u20139.","journal-title":"Neurosci Lett"},{"key":"916_CR307","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.brainres.2010.06.018","volume":"1348","author":"Q Zhang","year":"2010","unstructured":"Zhang Q, Yu J-T, Zhu Q-X, Zhang W, Wu Z-C, Miao D, et al. Complement receptor 1 polymorphisms and risk of late-onset alzheimer\u2019s disease. Brain Res. 2010;1348:216\u201321.","journal-title":"Brain Res"},{"key":"916_CR308","doi-asserted-by":"publisher","first-page":"e44317","DOI":"10.1016\/j.neurobiolaging.2013.08.009","volume":"35","author":"X-Y Ma","year":"2014","unstructured":"Ma X-Y, Yu J-T, Tan M-S, Sun F-R, Miao D, Tan L. Missense variants in CR1 are associated with increased risk of alzheimer\u2019 disease in Han Chinese. Neurobiol Aging. 2014;35:e44317\u201321.","journal-title":"Neurobiol Aging"},{"key":"916_CR309","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00439-018-1883-2","volume":"137","author":"E Kucukkilic","year":"2018","unstructured":"Kucukkilic E, Brookes K, Barber I, Guetta-Baranes T, Consortium ARUK, Morgan K, et al. Complement receptor 1 gene (CR1) intragenic duplication and risk of alzheimer\u2019s disease. Hum Genet. 2018;137:305\u201314.","journal-title":"Hum Genet"},{"key":"916_CR310","doi-asserted-by":"publisher","first-page":"e29495","DOI":"10.1016\/j.neurobiolaging.2012.07.001","volume":"33","author":"L-N Hazrati","year":"2012","unstructured":"Hazrati L-N, Van Cauwenberghe C, Brooks PL, Brouwers N, Ghani M, Sato C, et al. Genetic association of CR1 with alzheimer\u2019s disease: a tentative disease mechanism. Neurobiol Aging. 2012;33:e29495\u2013294912.","journal-title":"Neurobiol Aging"},{"key":"916_CR311","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.imbio.2011.07.017","volume":"217","author":"H Crehan","year":"2012","unstructured":"Crehan H, Holton P, Wray S, Pocock J, Guerreiro R, Hardy J. Complement receptor 1 (CR1) and alzheimer\u2019s disease. Immunobiology. 2012;217:244\u201350.","journal-title":"Immunobiology"},{"key":"916_CR312","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/ana.22277","volume":"69","author":"LB Chibnik","year":"2011","unstructured":"Chibnik LB, Shulman JM, Leurgans SE, Schneider JA, Wilson RS, Tran D, et al. CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol. 2011;69:560\u20139.","journal-title":"Ann Neurol"},{"key":"916_CR313","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1212\/WNL.0b013e3182452b40","volume":"78","author":"A Biffi","year":"2012","unstructured":"Biffi A, Shulman JM, Jagiella JM, Cortellini L, Ayres AM, Schwab K, et al. Genetic variation at CR1 increases risk of cerebral amyloid angiopathy. Neurology. 2012;78:334\u201341.","journal-title":"Neurology"},{"key":"916_CR314","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.neulet.2011.12.059","volume":"510","author":"G Hamilton","year":"2012","unstructured":"Hamilton G, Evans KL, Macintyre DJ, Deary IJ, Dominiczak A, Smith BH, et al. Alzheimer\u2019s disease risk factor complement receptor 1 is associated with depression. Neurosci Lett. 2012;510:6\u20139.","journal-title":"Neurosci Lett"},{"key":"916_CR315","doi-asserted-by":"publisher","first-page":"e0149792","DOI":"10.1371\/journal.pone.0149792","volume":"11","author":"MI Fonseca","year":"2016","unstructured":"Fonseca MI, Chu S, Pierce AL, Brubaker WD, Hauhart RE, Mastroeni D, et al. Analysis of the putative role of CR1 in alzheimer\u2019s disease: genetic association, expression and function. PLoS ONE. 2016;11:e0149792.","journal-title":"PLoS ONE"},{"key":"916_CR316","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1093\/hmg\/dds054","volume":"21","author":"BT Keenan","year":"2012","unstructured":"Keenan BT, Shulman JM, Chibnik LB, Raj T, Tran D, Sabuncu MR, et al. A coding variant in CR1 interacts with APOE-\u025b4 to influence cognitive decline. Hum Mol Genet. 2012;21:2377\u201388.","journal-title":"Hum Mol Genet"},{"key":"916_CR317","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1212\/NXG.0000000000000022","volume":"1","author":"A Lazaris","year":"2015","unstructured":"Lazaris A, Hwang KS, Goukasian N, Ramirez LM, Eastman J, Blanken AE, et al. Alzheimer risk genes modulate the relationship between plasma ApoE and cortical PiB binding. Neurol Genet. 2015;1:e22.","journal-title":"Neurol Genet"},{"key":"916_CR318","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/ng.976","volume":"43","author":"S Raychaudhuri","year":"2011","unstructured":"Raychaudhuri S, Iartchouk O, Chin K, Tan PL, Tai AK, Ripke S, et al. A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat Genet. 2011;43:1232\u20136.","journal-title":"Nat Genet"},{"key":"916_CR319","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/ajmg.b.30668","volume":"147B","author":"M Zetterberg","year":"2008","unstructured":"Zetterberg M, Landgren S, Andersson ME, Palm\u00e9r MS, Gustafson DR, Skoog I, et al. Association of complement factor H Y402H gene polymorphism with alzheimer\u2019s disease. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:720\u20136.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"916_CR320","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/npp.2015.232","volume":"41","author":"D-F Zhang","year":"2016","unstructured":"Zhang D-F, Li J, Wu H, Cui Y, Bi R, Zhou H-J, et al. CFH variants affect structural and functional brain changes and genetic risk of alzheimer\u2019s disease. Neuropsychopharmacology. 2016;41:1034\u201345.","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"916_CR321","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12974-023-02850-6","volume":"20","author":"A Veteleanu","year":"2023","unstructured":"Veteleanu A, Stevenson-Hoare J, Keat S, Daskoulidou N, Zetterberg H, Heslegrave A, et al. Alzheimer\u2019s disease-associated complement gene variants influence plasma complement protein levels. J Neuroinflammation. 2023;20(1):169.","journal-title":"J Neuroinflammation"},{"key":"916_CR322","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00406-022-01409-5","volume":"272","author":"A Hatzimanolis","year":"2022","unstructured":"Hatzimanolis A, Foteli S, Stefanatou P, Ntigrintaki A-A, Ralli I, Kollias K, et al. Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability. Eur Arch Psychiatry Clin Neurosci. 2022;272:1219\u201328.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"916_CR323","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.bbi.2024.03.041","volume":"119","author":"ML Baum","year":"2024","unstructured":"Baum ML, Wilton DK, Fox RG, Carey A, Hsu Y-HH, Hu R, et al. CSMD1 regulates brain complement activity and circuit development. Brain Behav Immun. 2024;119:317\u201332.","journal-title":"Brain Behav Immun"},{"key":"916_CR324","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/bpa.12880","volume":"30","author":"DLA van den Hove","year":"2020","unstructured":"van den Hove DLA, Riemens RJM, Koulousakis P, Pishva E. Epigenome-wide association studies in alzheimer\u2019s disease; achievements and challenges. Brain Pathol. 2020;30:978\u201383.","journal-title":"Brain Pathol"},{"issue":"8","key":"916_CR325","doi-asserted-by":"publisher","first-page":"10511","DOI":"10.1007\/s12035-025-04862-0","volume":"62","author":"S-Y Xu","year":"2025","unstructured":"Xu S-Y, Zhang S, Zeng C-L, Peng Y-J, Xu M. Emerging trends and hot spots in epigenetic modifications in neurology: A bibliometric analysis. Mol Neurobiol. 2025;62(8):10511\u201329.","journal-title":"Mol Neurobiol"},{"key":"916_CR326","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.tig.2022.03.010","volume":"38","author":"AL Mattei","year":"2022","unstructured":"Mattei AL, Bailly N, Meissner A. DNA methylation: a historical perspective. Trends Genet. 2022;38:676\u2013707.","journal-title":"Trends Genet"},{"key":"916_CR327","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/ajmg.b.32201","volume":"162B","author":"K Lunnon","year":"2013","unstructured":"Lunnon K, Mill J. Epigenetic studies in alzheimer\u2019s disease: current findings, caveats, and considerations for future studies. Am J Med Genet B Neuropsychiatr Genet. 2013;162B:789\u201399.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"916_CR328","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/bs.pmbts.2018.04.008","volume":"158","author":"R Lardenoije","year":"2018","unstructured":"Lardenoije R, Pishva E, van den Lunnon K. Neuroepigenetics of aging and age-related neurodegenerative disorders. Prog Mol Biol Transl Sci. 2018;158:49\u201382.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"916_CR329","doi-asserted-by":"publisher","first-page":"e0239196","DOI":"10.1371\/journal.pone.0239196","volume":"15","author":"R Mitsumori","year":"2020","unstructured":"Mitsumori R, Sakaguchi K, Shigemizu D, Mori T, Akiyama S, Ozaki K, et al. Lower DNA methylation levels in CpG Island Shores of CR1, CLU, and PICALM in the blood of Japanese alzheimer\u2019s disease patients. PLoS ONE. 2020;15:e0239196.","journal-title":"PLoS ONE"},{"key":"916_CR330","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/acn3.201","volume":"2","author":"LB Chibnik","year":"2015","unstructured":"Chibnik LB, Yu L, Eaton ML, Srivastava G, Schneider JA, Kellis M, et al. Alzheimer\u2019s loci: epigenetic associations and interaction with genetic factors. Ann Clin Transl Neurol. 2015;2:636\u201347.","journal-title":"Ann Clin Transl Neurol"},{"key":"916_CR331","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.psychres.2018.12.134","volume":"272","author":"M Alfimova","year":"2019","unstructured":"Alfimova M, Kondratyev N, Golov A, Golimbet V. Relationship between alzheimer\u2019s disease-associated SNPs within the CLU gene, local DNA methylation and episodic verbal memory in healthy and schizophrenia subjects. Psychiatry Res. 2019;272:380\u20136.","journal-title":"Psychiatry Res"},{"key":"916_CR332","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1186\/s12967-024-05680-z","volume":"22","author":"X-X Zhang","year":"2024","unstructured":"Zhang X-X, Wei M, Wang H-R, Hu Y-Z, Sun H-M, Jia J-J. Mitochondrial dysfunction gene expression, DNA methylation, and inflammatory cytokines interaction activate alzheimer\u2019s disease: a multi-omics Mendelian randomization study. J Transl Med. 2024;22:893.","journal-title":"J Transl Med"},{"key":"916_CR333","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1042\/BJ20051190","volume":"395","author":"F Loison","year":"2006","unstructured":"Loison F, Debure L, Nizard P, le Goff P, Michel D, le Dr\u00e9an Y. Up-regulation of the clusterin gene after proteotoxic stress: implication of HSF1-HSF2 heterocomplexes. Biochem J. 2006;395:223\u201331.","journal-title":"Biochem J"},{"key":"916_CR334","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/ijc.23658","volume":"123","author":"HE Rauhala","year":"2008","unstructured":"Rauhala HE, Porkka KP, Saram\u00e4ki OR, Tammela TLJ, Visakorpi T. Clusterin is epigenetically regulated in prostate cancer. Int J Cancer. 2008;123:1601\u20139.","journal-title":"Int J Cancer"},{"key":"916_CR335","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.neuint.2005.07.007","volume":"47","author":"T Nuutinen","year":"2005","unstructured":"Nuutinen T, Suuronen T, Kyrylenko S, Huuskonen J, Salminen A. Induction of clusterin\/apoJ expression by histone deacetylase inhibitors in neural cells. Neurochem Int. 2005;47:528\u201338.","journal-title":"Neurochem Int"},{"key":"916_CR336","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.bbrc.2007.03.135","volume":"357","author":"T Suuronen","year":"2007","unstructured":"Suuronen T, Nuutinen T, Ryh\u00e4nen T, Kaarniranta K, Salminen A. Epigenetic regulation of clusterin\/apolipoprotein J expression in retinal pigment epithelial cells. Biochem Biophys Res Commun. 2007;357:397\u2013401.","journal-title":"Biochem Biophys Res Commun"},{"key":"916_CR337","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13072-018-0211-3","volume":"11","author":"G Gasparoni","year":"2018","unstructured":"Gasparoni G, Bultmann S, Lutsik P, Kraus TFJ, Sordon S, Vlcek J, et al. DNA methylation analysis on purified neurons and glia dissects age and alzheimer\u2019s disease-specific changes in the human cortex. Epigenetics Chromatin. 2018;11:41.","journal-title":"Epigenetics Chromatin"},{"key":"916_CR338","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40478-021-01177-8","volume":"9","author":"L Zhang","year":"2021","unstructured":"Zhang L, Young JI, Gomez L, Silva TC, Schmidt MA, Cai J, et al. Sex-specific DNA methylation differences in alzheimer\u2019s disease pathology. Acta Neuropathol Commun. 2021;9:77.","journal-title":"Acta Neuropathol Commun"},{"key":"916_CR339","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41576-022-00468-7","volume":"23","author":"G Mill\u00e1n-Zambrano","year":"2022","unstructured":"Mill\u00e1n-Zambrano G, Burton A, Bannister AJ, Schneider R. Histone post-translational modifications - cause and consequence of genome function. Nat Rev Genet. 2022;23:563\u201380.","journal-title":"Nat Rev Genet"},{"key":"916_CR340","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.molcel.2024.10.034","volume":"85","author":"L L\u00f3pez-Hern\u00e1ndez","year":"2025","unstructured":"L\u00f3pez-Hern\u00e1ndez L, Toolan-Kerr P, Bannister AJ, Mill\u00e1n-Zambrano G. Dynamic histone modification patterns coordinating DNA processes. Mol Cell. 2025;85:225\u201337.","journal-title":"Mol Cell"},{"key":"916_CR341","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nature14252","volume":"518","author":"E Gjoneska","year":"2015","unstructured":"Gjoneska E, Pfenning AR, Mathys H, Quon G, Kundaje A, Tsai L-H, et al. Conserved epigenomic signals in mice and humans reveal immune basis of alzheimer\u2019s disease. Nature. 2015;518:365\u20139.","journal-title":"Nature"},{"key":"916_CR342","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/s41593-018-0253-7","volume":"21","author":"SJ Marzi","year":"2018","unstructured":"Marzi SJ, Leung SK, Ribarska T, Hannon E, Smith AR, Pishva E, et al. A histone acetylome-wide association study of alzheimer\u2019s disease identifies disease-associated H3K27ac differences in the entorhinal cortex. Nat Neurosci. 2018;21:1618\u201327.","journal-title":"Nat Neurosci"},{"key":"916_CR343","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1126\/science.aay0793","volume":"366","author":"A Nott","year":"2019","unstructured":"Nott A, Holtman IR, Coufal NG, Schlachetzki JCM, Yu M, Hu R, et al. Brain cell type-specific enhancer-promoter interactome maps and disease-risk association. Science. 2019;366:1134\u20139.","journal-title":"Science"},{"key":"916_CR344","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nn.3318","volume":"16","author":"K Kierdorf","year":"2013","unstructured":"Kierdorf K, Erny D, Goldmann T, Sander V, Schulz C, Perdiguero EG, et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat Neurosci. 2013;16:273\u201380.","journal-title":"Nat Neurosci"},{"key":"916_CR345","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nn.3599","volume":"17","author":"O Butovsky","year":"2014","unstructured":"Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, et al. Identification of a unique TGF-\u03b2-dependent molecular and functional signature in microglia. Nat Neurosci. 2014;17:131\u201343.","journal-title":"Nat Neurosci"},{"key":"916_CR346","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1038\/s41467-024-48484-x","volume":"15","author":"B Kim","year":"2024","unstructured":"Kim B, Dabin LC, Tate MD, Karahan H, Sharify AD, Acri DJ, et al. Effects of SPI1-mediated transcriptome remodeling on alzheimer\u2019s disease-related phenotypes in mouse models of A\u03b2 amyloidosis. Nat Commun. 2024;15:3996.","journal-title":"Nat Commun"},{"key":"916_CR347","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","volume":"12","author":"M Esteller","year":"2011","unstructured":"Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12:861\u201374.","journal-title":"Nat Rev Genet"},{"key":"916_CR348","doi-asserted-by":"publisher","first-page":"31315","DOI":"10.1074\/jbc.M805371200","volume":"283","author":"WJ Lukiw","year":"2008","unstructured":"Lukiw WJ, Zhao Y, Cui JG. An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in alzheimer disease and in stressed human brain cells. J Biol Chem. 2008;283:31315\u201322.","journal-title":"J Biol Chem"},{"key":"916_CR349","first-page":"105","volume":"3","author":"WJ Lukiw","year":"2012","unstructured":"Lukiw WJ, Surjyadipta B, Dua P, Alexandrov PN. Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in alzheimer\u2019s disease (AD) and in age-related macular degeneration (AMD). Int J Biochem Mol Biol. 2012;3:105\u201316.","journal-title":"Int J Biochem Mol Biol"},{"key":"916_CR350","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12035-012-8234-4","volume":"46","author":"WJ Lukiw","year":"2012","unstructured":"Lukiw WJ, Alexandrov PN. Regulation of complement factor H (CFH) by multiple MiRNAs in alzheimer\u2019s disease (AD) brain. Mol Neurobiol. 2012;46:11\u20139.","journal-title":"Mol Neurobiol"},{"key":"916_CR351","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.jinorgbio.2009.05.012","volume":"103","author":"AI Pogue","year":"2009","unstructured":"Pogue AI, Li YY, Cui J-G, Zhao Y, Kruck TPA, Percy ME, et al. Characterization of an NF-kappaB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells. J Inorg Biochem. 2009;103:1591\u20135.","journal-title":"J Inorg Biochem"},{"key":"916_CR352","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neulet.2010.09.079","volume":"487","author":"YY Li","year":"2011","unstructured":"Li YY, Cui JG, Hill JM, Bhattacharjee S, Zhao Y, Lukiw WJ. Increased expression of miRNA-146a in alzheimer\u2019s disease Transgenic mouse models. Neurosci Lett. 2011;487:94\u20138.","journal-title":"Neurosci Lett"},{"key":"916_CR353","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neulet.2011.05.044","volume":"499","author":"YY Li","year":"2011","unstructured":"Li YY, Cui JG, Dua P, Pogue AI, Bhattacharjee S, Lukiw WJ. Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells. Neurosci Lett. 2011;499:109\u201313.","journal-title":"Neurosci Lett"},{"issue":"2","key":"916_CR354","first-page":"312","volume":"7","author":"V Jaber","year":"2017","unstructured":"Jaber V, Zhao Y, Lukiw WJ. Alterations in micro RNA-messenger RNA (miRNA-mRNA) coupled signaling networks in sporadic alzheimer\u2019s disease (AD) hippocampal CA1. J Alzheimers Dis Parkinsonism. 2017;7(2):312.","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"916_CR355","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/WNR.0b013e32834f4eb4","volume":"23","author":"YY Li","year":"2012","unstructured":"Li YY, Alexandrov PN, Pogue AI, Zhao Y, Bhattacharjee S, Lukiw WJ. miRNA-155 upregulation and complement factor H deficits in down\u2019s syndrome. NeuroReport. 2012;23:168\u201373.","journal-title":"NeuroReport"},{"key":"916_CR356","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fneur.2015.00232","volume":"6","author":"JM Hill","year":"2015","unstructured":"Hill JM, Pogue AI, Lukiw WJ. Pathogenic MicroRNAs common to brain and retinal degeneration; recent observations in alzheimer\u2019s disease and age-related macular degeneration. Front Neurol. 2015;6:232.","journal-title":"Front Neurol"},{"issue":"2","key":"916_CR357","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.4081\/ejh.2019.3008","volume":"63","author":"N Xu","year":"2019","unstructured":"Xu N, Li AD, Ji LL, Ye Y, Wang ZY, Tong L. miR-132 regulates the expression of synaptic proteins in APP\/PS1 Transgenic mice through C1q. Eur J Histochem. 2019;63(2):3008.","journal-title":"Eur J Histochem"},{"key":"916_CR358","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.brainresbull.2019.09.002","volume":"153","author":"A-D Li","year":"2019","unstructured":"Li A-D, Tong L, Xu N, Ye Y, Nie P-Y, Wang Z-Y, et al. miR-124 regulates cerebromicrovascular function in APP\/PS1 Transgenic mice via C1ql3. Brain Res Bull. 2019;153:214\u201322.","journal-title":"Brain Res Bull"},{"key":"916_CR359","doi-asserted-by":"publisher","first-page":"687973","DOI":"10.3389\/fnins.2021.687973","volume":"15","author":"M Zhang","year":"2021","unstructured":"Zhang M, Bian Z. Alzheimer\u2019s disease and microRNA-132: A widespread pathological factor and potential therapeutic target. Front Neurosci. 2021;15:687973.","journal-title":"Front Neurosci"},{"key":"916_CR360","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1038\/s41380-022-01476-z","volume":"27","author":"S Yoon","year":"2022","unstructured":"Yoon S, Kim SE, Ko Y, Jeong GH, Lee KH, Lee J, et al. Differential expression of MicroRNAs in alzheimer\u2019s disease: a systematic review and meta-analysis. Mol Psychiatry. 2022;27:2405\u201313.","journal-title":"Mol Psychiatry"},{"key":"916_CR361","doi-asserted-by":"publisher","first-page":"102483","DOI":"10.1016\/j.arr.2024.102483","volume":"101","author":"M Sharma","year":"2024","unstructured":"Sharma M, Pal P, Gupta SK. Deciphering the role of MiRNAs in alzheimer\u2019s disease: predictive targeting and pathway modulation - A systematic review. Ageing Res Rev. 2024;101:102483.","journal-title":"Ageing Res Rev"},{"key":"916_CR362","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3233\/JAD-2008-14103","volume":"14","author":"JP Cogswell","year":"2008","unstructured":"Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B, et al. Identification of MiRNA changes in alzheimer\u2019s disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis. 2008;14:27\u201341.","journal-title":"J Alzheimers Dis"},{"key":"916_CR363","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jconrel.2020.04.017","volume":"323","author":"R Upadhya","year":"2020","unstructured":"Upadhya R, Zingg W, Shetty S, Shetty AK. Astrocyte-derived extracellular vesicles: neuroreparative properties and role in the pathogenesis of neurodegenerative disorders. J Control Release. 2020;323:225\u201339.","journal-title":"J Control Release"},{"key":"916_CR364","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.3390\/ijms21145078","volume":"21","author":"WJ Lukiw","year":"2020","unstructured":"Lukiw WJ, Pogue AI. Vesicular transport of encapsulated MicroRNA between glial and neuronal cells. Int J Mol Sci. 2020;21:5078.","journal-title":"Int J Mol Sci"},{"key":"916_CR365","doi-asserted-by":"publisher","first-page":"899944","DOI":"10.3389\/fnagi.2022.899944","volume":"14","author":"S Weng","year":"2022","unstructured":"Weng S, Lai Q-L, Wang J, Zhuang L, Cheng L, Mo Y, et al. The role of exosomes as mediators of neuroinflammation in the pathogenesis and treatment of alzheimer\u2019s disease. Front Aging Neurosci. 2022;14:899944.","journal-title":"Front Aging Neurosci"},{"key":"916_CR366","doi-asserted-by":"publisher","first-page":"654978","DOI":"10.3389\/fnagi.2021.654978","volume":"13","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhao Y, Ao X, Yu W, Zhang L, Wang Y, et al. The role of non-coding RNAs in alzheimer\u2019s disease: from regulated mechanism to therapeutic targets and diagnostic biomarkers. Front Aging Neurosci. 2021;13:654978.","journal-title":"Front Aging Neurosci"},{"key":"916_CR367","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3233\/JAD-2011-110755","volume":"27","author":"F Licastro","year":"2011","unstructured":"Licastro F, Carbone I, Ianni M, Porcellini E. Gene signature in alzheimer\u2019s disease and environmental factors: the virus chronicle. J Alzheimers Dis. 2011;27:809\u201317.","journal-title":"J Alzheimers Dis"},{"key":"916_CR368","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.neuron.2019.12.015","volume":"105","author":"B Bai","year":"2020","unstructured":"Bai B, Wang X, Li Y, Chen P-C, Yu K, Dey KK, et al. Deep multilayer brain proteomics identifies molecular networks in alzheimer\u2019s disease progression. Neuron. 2020;105:975\u2013e917.","journal-title":"Neuron"},{"key":"916_CR369","doi-asserted-by":"publisher","first-page":"102353","DOI":"10.1016\/j.pneurobio.2022.102353","volume":"219","author":"PN Pallier","year":"2022","unstructured":"Pallier PN, Ferrara M, Romagnolo F, Ferretti MT, Soreq H, Cerase A. Chromosomal and environmental contributions to sex differences in the vulnerability to neurological and neuropsychiatric disorders: implications for therapeutic interventions. Prog Neurobiol. 2022;219:102353.","journal-title":"Prog Neurobiol"},{"key":"916_CR370","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12974-025-03404-8","volume":"22","author":"BT Casali","year":"2025","unstructured":"Casali BT, Lin L, Benedict O, Zuppe H, Marsico E, Reed EG. Sex chromosomes and gonads modify microglial-mediated pathology in a mouse model of alzheimer\u2019s disease. J Neuroinflammation. 2025;22:81.","journal-title":"J Neuroinflammation"},{"key":"916_CR371","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41420-024-01885-9","volume":"10","author":"M Ali","year":"2024","unstructured":"Ali M, Garcia P, Lunkes LP, Sciortino A, Thomas M, Heurtaux T, et al. Single cell transcriptome analysis of the THY-Tau22 mouse model of alzheimer\u2019s disease reveals sex-dependent dysregulations. Cell Death Discov. 2024;10:119.","journal-title":"Cell Death Discov"},{"key":"916_CR372","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13195-024-01492-x","volume":"16","author":"AJ Barber","year":"2024","unstructured":"Barber AJ, Del Genio CL, Swain AB, Pizzi EM, Watson SC, Tapiavala VN, et al. Age, sex and alzheimer\u2019s disease: a longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from alzheimer\u2019s patients. Alzheimers Res Ther. 2024;16:134.","journal-title":"Alzheimers Res Ther"},{"key":"916_CR373","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s12603-014-0552-y","volume":"18","author":"S Davinelli","year":"2014","unstructured":"Davinelli S, Calabrese V, Zella D, Scapagnini G. Epigenetic nutraceutical diets in alzheimer\u2019s disease. J Nutr Health Aging. 2014;18:800\u20135.","journal-title":"J Nutr Health Aging"},{"key":"916_CR374","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bbi.2024.07.021","volume":"121","author":"SE Mackey-Alfonso","year":"2024","unstructured":"Mackey-Alfonso SE, Butler MJ, Taylor AM, Williams-Medina AR, Muscat SM, Fu H, et al. Short-term high fat diet impairs memory, exacerbates the neuroimmune response, and evokes synaptic degradation via a complement-dependent mechanism in a mouse model of alzheimer\u2019s disease. Brain Behav Immun. 2024;121:56\u201369.","journal-title":"Brain Behav Immun"},{"key":"916_CR375","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-024-03080-0","volume":"21","author":"M Poxleitner","year":"2024","unstructured":"Poxleitner M, Hoffmann SHL, Berezhnoy G, Ionescu TM, Gonzalez-Menendez I, Maier FC, et al. Western diet increases brain metabolism and adaptive immune responses in a mouse model of amyloidosis. J Neuroinflammation. 2024;21:129.","journal-title":"J Neuroinflammation"},{"issue":"Suppl 1","key":"916_CR376","first-page":"S457","volume":"33","author":"P Barberger-Gateau","year":"2013","unstructured":"Barberger-Gateau P, Lambert J-C, F\u00e9art C, P\u00e9r\u00e8s K, Ritchie K, Dartigues J-F, et al. From genetics to dietetics: the contribution of epidemiology to Understanding alzheimer\u2019s disease. J Alzheimers Dis. 2013;33(Suppl 1):S457\u201363.","journal-title":"J Alzheimers Dis"},{"key":"916_CR377","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41586-021-04183-x","volume":"600","author":"Z De Miguel","year":"2021","unstructured":"De Miguel Z, Khoury N, Betley MJ, Lehallier B, Willoughby D, Olsson N, et al. Exercise plasma boosts memory and dampens brain inflammation via clusterin. Nature. 2021;600:494\u20139.","journal-title":"Nature"},{"key":"916_CR378","doi-asserted-by":"publisher","first-page":"122042","DOI":"10.1016\/j.lfs.2023.122042","volume":"331","author":"J Yang","year":"2023","unstructured":"Yang J, Yuan S, Jian Y, Lei Y, Hu Z, Yang Q, et al. Aerobic exercise regulates GPR81 signal pathway and mediates complement- microglia axis homeostasis on synaptic protection in the early stage of alzheimer\u2019s disease. Life Sci. 2023;331:122042.","journal-title":"Life Sci"},{"key":"916_CR379","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12868-023-00836-x","volume":"24","author":"A Kolonics","year":"2023","unstructured":"Kolonics A, Bori Z, Torma F, Abraham D, Feh\u00e9r J, Radak Z. Exercise combined with postbiotics treatment results in synergistic improvement of mitochondrial function in the brain of male Transgenic mice for alzheimer\u2019s disease. BMC Neurosci. 2023;24:68.","journal-title":"BMC Neurosci"},{"key":"916_CR380","first-page":"29","volume-title":"An overview of our gut microbiome. Probiotics","author":"S Shatakshi, Dhyani","year":"2024","unstructured":"Shatakshi, Dhyani S, Chaurasia H, Kumar H. An overview of our gut microbiome. Probiotics. Boca Raton: CRC; 2024. pp. 29\u201355."},{"key":"916_CR381","doi-asserted-by":"publisher","first-page":"102570","DOI":"10.1016\/j.arr.2024.102570","volume":"102","author":"B Kapoor","year":"2024","unstructured":"Kapoor B, Biswas P, Gulati M, Rani P, Gupta R. Gut Microbiome and alzheimer\u2019s disease: what we know and what remains to be explored. Ageing Res Rev. 2024;102:102570.","journal-title":"Ageing Res Rev"},{"key":"916_CR382","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.mucimm.2024.05.006","volume":"17","author":"DH Kulkarni","year":"2024","unstructured":"Kulkarni DH, Starick M, Aponte Alburquerque R, Kulkarni HS. Local complement activation and modulation in mucosal immunity. Mucosal Immunol. 2024;17:739\u201351.","journal-title":"Mucosal Immunol"},{"key":"916_CR383","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nri3608","volume":"14","author":"LW Peterson","year":"2014","unstructured":"Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol. 2014;14:141\u201353.","journal-title":"Nat Rev Immunol"},{"key":"916_CR384","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41232-018-0063-z","volume":"38","author":"R Okumura","year":"2018","unstructured":"Okumura R, Takeda K. Maintenance of intestinal homeostasis by mucosal barriers. Inflamm Regen. 2018;38:5.","journal-title":"Inflamm Regen"},{"key":"916_CR385","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.2147\/JIR.S384949","volume":"15","author":"Y Han","year":"2022","unstructured":"Han Y, Wang B, Gao H, He C, Hua R, Liang C, et al. Vagus nerve and underlying impact on the gut Microbiota-brain axis in behavior and neurodegenerative diseases. J Inflamm Res. 2022;15:6213\u201330.","journal-title":"J Inflamm Res"},{"key":"916_CR386","first-page":"28","volume":"17","author":"J Appleton","year":"2018","unstructured":"Appleton J. The gut-brain axis: influence of microbiota on mood and mental health. Integr Med (Encinitas). 2018;17:28\u201332.","journal-title":"Integr Med (Encinitas)"},{"key":"916_CR387","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/postgradmedj-2017-135424","volume":"94","author":"BM Arneth","year":"2018","unstructured":"Arneth BM. Gut\u2013brain axis biochemical signalling from the Gastrointestinal tract to the central nervous system: gut dysbiosis and altered brain function. Postgrad Med J. 2018;94:446\u201352.","journal-title":"Postgrad Med J"},{"issue":"1","key":"916_CR388","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11481-024-10107-z","volume":"19","author":"Y Chen","year":"2024","unstructured":"Chen Y, Chu JM, Wong GT, Chang RC. Complement C3 from astrocytes plays significant roles in sustained activation of microglia and cognitive dysfunctions triggered by systemic inflammation after laparotomy in adult male mice. J Neuroimmune Pharmacol. 2024;19(1):8.","journal-title":"J Neuroimmune Pharmacol"},{"key":"916_CR389","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol. 2017;35:441\u201368.","journal-title":"Annu Rev Immunol"},{"key":"916_CR390","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3390\/microorganisms10030578","volume":"10","author":"T Hrncir","year":"2022","unstructured":"Hrncir T. Gut microbiota dysbiosis: Triggers, consequences, diagnostic and therapeutic options. Microorganisms. 2022;10:578.","journal-title":"Microorganisms"},{"issue":"6","key":"916_CR391","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S2468-1253(24)00390-X","volume":"10","author":"MF Neurath","year":"2025","unstructured":"Neurath MF, Artis D, Becker C. The intestinal barrier: a pivotal role in health, inflammation, and cancer. Lancet Gastroenterol Hepatol. 2025;10(6):573\u201392.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"916_CR392","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/mi.2016.75","volume":"10","author":"MY Zeng","year":"2017","unstructured":"Zeng MY, Inohara N, Nu\u00f1ez G. Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol. 2017;10:18\u201326.","journal-title":"Mucosal Immunol"},{"key":"916_CR393","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1007\/s00210-023-02554-x","volume":"396","author":"A Thakkar","year":"2023","unstructured":"Thakkar A, Vora A, Kaur G, Akhtar J. Dysbiosis and alzheimer\u2019s disease: role of probiotics, prebiotics and synbiotics. Naunyn Schmiedebergs Arch Pharmacol. 2023;396:2911\u201323.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"916_CR394","doi-asserted-by":"publisher","first-page":"e42925","DOI":"10.1016\/j.heliyon.2025.e42925","volume":"11","author":"Z Zou","year":"2025","unstructured":"Zou Z, Lei D, Yin Y, Xu R, Luo H, Chen T, et al. Frequent fecal microbiota transplantation improves cognitive impairment and pathological changes in alzheimer\u2019s disease FAD4T mice via the microbiota-gut-brain axis. Heliyon. 2025;11:e42925.","journal-title":"Heliyon"},{"issue":"4","key":"916_CR395","doi-asserted-by":"crossref","first-page":"e00261","DOI":"10.1128\/mSystems.00261-19","volume":"4","author":"J de la Cuesta-Zuluaga","year":"2019","unstructured":"de la Cuesta-Zuluaga J, Kelley ST, Chen Y, Escobar JS, Mueller NT, Ley RE, et al. Age- and Sex-Dependent patterns of gut microbial diversity in human adults. mSystems. 2019;4(4):e00261\u201319.","journal-title":"mSystems"},{"issue":"1","key":"916_CR396","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12868-025-00953-9","volume":"26","author":"P Upadhyay","year":"2025","unstructured":"Upadhyay P, Kumar S, Tyagi A, Tyagi AR, Barbhuyan T, Gupta S. Gut Microbiome rewiring via fecal transplants: Uncovering therapeutic avenues in alzheimer\u2019s disease models. BMC Neurosci. 2025;26(1):39.","journal-title":"BMC Neurosci"},{"key":"916_CR397","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.3390\/ijms23052679","volume":"23","author":"S Imdad","year":"2022","unstructured":"Imdad S, Lim W, Kim J-H, Kang C. Intertwined relationship of mitochondrial metabolism, gut Microbiome and exercise potential. Int J Mol Sci. 2022;23:2679.","journal-title":"Int J Mol Sci"},{"key":"916_CR398","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nn.4030","volume":"18","author":"D Erny","year":"2015","unstructured":"Erny D, Hrab\u011b de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015;18:965\u201377.","journal-title":"Nat Neurosci"},{"key":"916_CR399","doi-asserted-by":"publisher","first-page":"106530","DOI":"10.1016\/j.phrs.2022.106530","volume":"186","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang J, Duan L. The role of microbiota-mitochondria crosstalk in pathogenesis and therapy of intestinal diseases. Pharmacol Res. 2022;186:106530.","journal-title":"Pharmacol Res"},{"issue":"24","key":"916_CR400","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.3390\/nu15245116","volume":"15","author":"M Fekete","year":"2023","unstructured":"Fekete M, Lehoczki A, Tarantini S, Fazekas-Pongor V, Cs\u00edp\u0151 T, Csizmadia Z, Varga JT. Improving cognitive function with nutritional supplements in aging: A comprehensive narrative review of clinical studies investigating the effects of Vitamins, Minerals, Antioxidants, and other dietary supplements. Nutrients. 2023;15(24):5116.","journal-title":"Nutrients"},{"key":"916_CR401","doi-asserted-by":"publisher","first-page":"109452","DOI":"10.1016\/j.cbi.2021.109452","volume":"341","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Li K, Li X, Xu L, Yang Z. Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice. Chem Biol Interact. 2021;341:109452.","journal-title":"Chem Biol Interact"},{"key":"916_CR402","doi-asserted-by":"publisher","first-page":"e0017825","DOI":"10.1128\/spectrum.00178-25","volume":"13","author":"Y Shiqing","year":"2025","unstructured":"Shiqing Y, Xinjie L, Xiaotong Z, Jiayan C, Jiahai L, Xiaodong C, et al. Clostridium Butyricum enhances cognitive function in APP\/PS1 mice by modulating neuropathology and regulating acetic acid levels in the gut microbiota. Microbiol Spectr. 2025;13:e0017825.","journal-title":"Microbiol Spectr"},{"key":"916_CR403","doi-asserted-by":"crossref","unstructured":"Colombo AV, Sadler RK, Llovera G, Singh V, Roth S, Heindl S. Microbiota-derived short chain fatty acids modulate microglia and promote Abeta plaque deposition. 2021.","DOI":"10.7554\/eLife.59826.sa2"},{"key":"916_CR404","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/j.cmet.2021.10.010","volume":"33","author":"D Erny","year":"2021","unstructured":"Erny D, Dokalis N, Mez\u00f6 C, Castoldi A, Mossad O, Staszewski O, et al. Microbiota-derived acetate enables the metabolic fitness of the brain innate immune system during health and disease. Cell Metab. 2021;33:2260\u2013e767.","journal-title":"Cell Metab"},{"key":"916_CR405","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41392-024-01743-1","volume":"9","author":"JS Loh","year":"2024","unstructured":"Loh JS, Mak WQ, Tan LKS, Ng CX, Chan HH, Yeow SH, et al. Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther. 2024;9:37.","journal-title":"Signal Transduct Target Ther"},{"key":"916_CR406","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","volume":"33","author":"M Noris","year":"2013","unstructured":"Noris M, Remuzzi G. Overview of complement activation and regulation. Semin Nephrol. 2013;33:479\u201392.","journal-title":"Semin Nephrol"},{"key":"916_CR407","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.cell.2023.12.036","volume":"187","author":"M Wu","year":"2024","unstructured":"Wu M, Zheng W, Song X, Bao B, Wang Y, Ramanan D, et al. Gut complement induced by the microbiota combats pathogens and spares commensals. Cell. 2024;187:897\u2013e91318.","journal-title":"Cell"},{"key":"916_CR408","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00281-017-0662-9","volume":"40","author":"BP Morgan","year":"2018","unstructured":"Morgan BP. Complement in the pathogenesis of alzheimer\u2019s disease. Semin Immunopathol. 2018;40:113\u201324.","journal-title":"Semin Immunopathol"},{"key":"916_CR409","doi-asserted-by":"publisher","first-page":"13537","DOI":"10.1038\/s41598-017-13601-y","volume":"7","author":"NM Vogt","year":"2017","unstructured":"Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC, et al. Gut Microbiome alterations in alzheimer\u2019s disease. Sci Rep. 2017;7:13537.","journal-title":"Sci Rep"},{"key":"916_CR410","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3233\/JAD-180176","volume":"63","author":"Z-Q Zhuang","year":"2018","unstructured":"Zhuang Z-Q, Shen L-L, Li W-W, Fu X, Zeng F, Gui L, et al. Gut microbiota is altered in patients with alzheimer\u2019s disease. J Alzheimers Dis. 2018;63:1337\u201346.","journal-title":"J Alzheimers Dis"},{"key":"916_CR411","doi-asserted-by":"publisher","first-page":"e00426","DOI":"10.1016\/j.neurot.2024.e00426","volume":"21","author":"P Saha","year":"2024","unstructured":"Saha P, Sisodia SS. Role of the gut Microbiome in mediating sex-specific differences in the pathophysiology of alzheimer\u2019s disease. Neurotherapeutics. 2024;21:e00426.","journal-title":"Neurotherapeutics"},{"key":"916_CR412","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3233\/JAD-160926","volume":"56","author":"C Brandscheid","year":"2017","unstructured":"Brandscheid C, Schuck F, Reinhardt S, Sch\u00e4fer K-H, Pietrzik CU, Grimm M, et al. Altered gut Microbiome composition and tryptic activity of the 5xFAD alzheimer\u2019s mouse model. J Alzheimers Dis. 2017;56:775\u201388.","journal-title":"J Alzheimers Dis"},{"key":"916_CR413","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1136\/gutjnl-2021-326269","volume":"71","author":"C Chen","year":"2022","unstructured":"Chen C, Liao J, Xia Y, Liu X, Jones R, Haran J, et al. Gut microbiota regulate alzheimer\u2019s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation. Gut. 2022;71:2233\u201352.","journal-title":"Gut"},{"key":"916_CR414","doi-asserted-by":"publisher","first-page":"e0179422","DOI":"10.1128\/mbio.01794-22","volume":"13","author":"SJB Dunham","year":"2022","unstructured":"Dunham SJB, McNair KA, Adams ED, Avelar-Barragan J, Forner S, Mapstone M, et al. Longitudinal analysis of the Microbiome and metabolome in the 5xfAD mouse model of alzheimer\u2019s disease. MBio. 2022;13:e0179422.","journal-title":"MBio"},{"key":"916_CR415","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.2174\/1570159X22666240308090741","volume":"22","author":"C Liang","year":"2024","unstructured":"Liang C, Pereira R, Zhang Y, Rojas OL. Gut Microbiome in alzheimer\u2019s disease: from mice to humans. Curr Neuropharmacol. 2024;22:2314\u201329.","journal-title":"Curr Neuropharmacol"},{"key":"916_CR416","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.chom.2009.05.020","volume":"6","author":"C T\u00fckel","year":"2009","unstructured":"T\u00fckel C, Wilson RP, Nishimori JH, Pezeshki M, Chromy BA, B\u00e4umler AJ. Responses to amyloids of microbial and host origin are mediated through toll-like receptor 2. Cell Host Microbe. 2009;6:45\u201353.","journal-title":"Cell Host Microbe"},{"key":"916_CR417","doi-asserted-by":"publisher","first-page":"e1006654","DOI":"10.1371\/journal.ppat.1006654","volume":"13","author":"RP Friedland","year":"2017","unstructured":"Friedland RP, Chapman MR. The role of microbial amyloid in neurodegeneration. PLoS Pathog. 2017;13:e1006654.","journal-title":"PLoS Pathog"},{"key":"916_CR418","doi-asserted-by":"publisher","first-page":"5376","DOI":"10.1038\/s41598-024-55423-9","volume":"14","author":"T Prosswimmer","year":"2024","unstructured":"Prosswimmer T, Heng A, Daggett V. Mechanistic insights into the role of amyloid-\u03b2 in innate immunity. Sci Rep. 2024;14:5376.","journal-title":"Sci Rep"},{"key":"916_CR419","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2119\/2007-00100.Irvine","volume":"14","author":"GB Irvine","year":"2008","unstructured":"Irvine GB, El-Agnaf OM, Shankar GM, Walsh DM. Protein aggregation in the brain: the molecular basis for alzheimer\u2019s and parkinson\u2019s diseases. Mol Med. 2008;14:451\u201364.","journal-title":"Mol Med"},{"key":"916_CR420","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of alzheimer\u2019s disease. Mol Neurodegener. 2019;14:32.","journal-title":"Mol Neurodegener"},{"key":"916_CR421","doi-asserted-by":"publisher","unstructured":"2025 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2025;21. Available from: https:\/\/doi.org\/10.1002\/alz.70235","DOI":"10.1002\/alz.70235"},{"key":"916_CR422","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","volume":"17","author":"BA Gordon","year":"2018","unstructured":"Gordon BA, Blazey TM, Su Y, Hari-Raj A, Dincer A, Flores S, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant alzheimer\u2019s disease: a longitudinal study. Lancet Neurol. 2018;17:241\u201350.","journal-title":"Lancet Neurol"},{"key":"916_CR423","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S1474-4422(20)30137-X","volume":"19","author":"YT Quiroz","year":"2020","unstructured":"Quiroz YT, Zetterberg H, Reiman EM, Chen Y, Su Y, Fox-Fuller JT, et al. Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant alzheimer\u2019s disease kindred: a cross-sectional and longitudinal cohort study. Lancet Neurol. 2020;19:513\u201321.","journal-title":"Lancet Neurol"},{"key":"916_CR424","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41591-020-0781-z","volume":"26","author":"NR Barth\u00e9lemy","year":"2020","unstructured":"Barth\u00e9lemy NR, Li Y, Joseph-Mathurin N, Gordon BA, Hassenstab J, Benzinger TLS, et al. A soluble phosphorylated Tau signature links Tau, amyloid and the evolution of stages of dominantly inherited alzheimer\u2019s disease. Nat Med. 2020;26:398\u2013407.","journal-title":"Nat Med"},{"key":"916_CR425","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/s43587-024-00675-3","volume":"4","author":"O Hansson","year":"2024","unstructured":"Hansson O, Jack CR Jr. A clinical perspective on the revised criteria for diagnosis and staging of alzheimer\u2019s disease. Nat Aging. 2024;4:1029\u201331.","journal-title":"Nat Aging"},{"key":"916_CR426","doi-asserted-by":"publisher","first-page":"a006213","DOI":"10.1101\/cshperspect.a006213","volume":"2","author":"KA Johnson","year":"2012","unstructured":"Johnson KA, Fox NC, Sperling RA, Klunk WE. Brain imaging in alzheimer disease. Cold Spring Harb Perspect Med. 2012;2:a006213\u2013006213.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"916_CR427","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.arcmed.2012.10.018","volume":"43","author":"G Rom\u00e1n","year":"2012","unstructured":"Rom\u00e1n G, Pascual B. Contribution of neuroimaging to the diagnosis of alzheimer\u2019s disease and vascular dementia. Arch Med Res. 2012;43:671\u20136.","journal-title":"Arch Med Res"},{"key":"916_CR428","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2217\/nmt-2022-0013","volume":"12","author":"H Hampel","year":"2022","unstructured":"Hampel H, Elhage A, Cummings J, Blennow K, Gao P, Jack CR Jr, et al. The AT(N) system for describing biological changes in alzheimer\u2019s disease: A plain Language summary. Neurodegener Dis Manag. 2022;12:231\u20139.","journal-title":"Neurodegener Dis Manag"},{"key":"916_CR429","doi-asserted-by":"publisher","first-page":"569","DOI":"10.14283\/jpad.2022.85","volume":"9","author":"D Angioni","year":"2022","unstructured":"Angioni D, Delrieu J, Hansson O, Fillit H, Aisen P, Cummings J, et al. Blood biomarkers from research use to clinical practice: what must be done? A report from the EU\/US CTAD task force. J Prev Alzheimers Dis. 2022;9:569\u201379.","journal-title":"J Prev Alzheimers Dis"},{"key":"916_CR430","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3390\/biomedicines10040850","volume":"10","author":"S Mankhong","year":"2022","unstructured":"Mankhong S, Kim S, Lee S, Kwak H-B, Park D-H, Joa K-L, et al. Development of alzheimer\u2019s disease biomarkers: from CSF- to blood-based biomarkers. Biomedicines. 2022;10:850.","journal-title":"Biomedicines"},{"key":"916_CR431","doi-asserted-by":"publisher","first-page":"100057","DOI":"10.1016\/j.medp.2024.100057","volume":"1","author":"J Shi","year":"2024","unstructured":"Shi J, Ou Q, Chen X. Blood-based biomarkers of alzheimer\u2019s disease\u2014A guideline for clinical use. Med Plus. 2024;1:100057.","journal-title":"Med Plus"},{"key":"916_CR432","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.1038\/s41467-023-42596-6","volume":"14","author":"H Cai","year":"2023","unstructured":"Cai H, Pang Y, Fu X, Ren Z, Jia L. Plasma biomarkers predict alzheimer\u2019s disease before clinical onset in Chinese cohorts. Nat Commun. 2023;14:6747.","journal-title":"Nat Commun"},{"key":"916_CR433","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jim.2004.12.018","volume":"298","author":"D Wouters","year":"2005","unstructured":"Wouters D, Wiessenberg HD, Hart M, Bruins P, Voskuyl A, Daha MR, et al. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation. J Immunol Methods. 2005;298:35\u201345.","journal-title":"J Immunol Methods"},{"key":"916_CR434","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1038\/s41380-019-0536-8","volume":"26","author":"SH Krance","year":"2021","unstructured":"Krance SH, Wu C-Y, Zou Y, Mao H, Toufighi S, He X, et al. The complement cascade in alzheimer\u2019s disease: a systematic review and meta-analysis. Mol Psychiatry. 2021;26:5532\u201341.","journal-title":"Mol Psychiatry"},{"key":"916_CR435","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0169-328X(00)00149-2","volume":"81","author":"R Strohmeyer","year":"2000","unstructured":"Strohmeyer R, Shen Y, Rogers J. Detection of complement alternative pathway mRNA and proteins in the alzheimer\u2019s disease brain. Brain Res Mol Brain Res. 2000;81:7\u201318.","journal-title":"Brain Res Mol Brain Res"},{"issue":"12","key":"916_CR436","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3390\/genes12121990","volume":"12","author":"M Torvell","year":"2021","unstructured":"Torvell M, Carpanini SM, Daskoulidou N, Byrne RAJ, Sims R, Morgan BP. Genetic insights into the impact of complement in alzheimer\u2019s disease. Genes (Basel). 2021;12(12):1990.","journal-title":"Genes (Basel)"},{"key":"916_CR437","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40478-016-0277-8","volume":"4","author":"WT Hu","year":"2016","unstructured":"Hu WT, Watts KD, Tailor P, Nguyen TP, Howell JC, Lee RC, Seyfried NT, Gearing M, Hales CM, Levey AI, Lah JJ, Lee EK. Alzheimer\u2019s disease Neuro-Imaging Initiative. CSF complement 3 and factor H are staging biomarkers in alzheimer\u2019s disease. Acta Neuropathol Commun. 2016;4:14.","journal-title":"Acta Neuropathol Commun"},{"key":"916_CR438","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13195-017-0319-x","volume":"9","author":"J-L Hsu","year":"2017","unstructured":"Hsu J-L, Lee W-J, Liao Y-C, Wang S-J, Fuh J-L. The clinical significance of plasma clusterin and A\u03b2 in the longitudinal follow-up of patients with alzheimer\u2019s disease. Alzheimers Res Ther. 2017;9:91.","journal-title":"Alzheimers Res Ther"},{"key":"916_CR439","doi-asserted-by":"publisher","first-page":"e0166369","DOI":"10.1371\/journal.pone.0166369","volume":"11","author":"VY Vishnu","year":"2016","unstructured":"Vishnu VY, Modi M, Sharma S, Mohanty M, Goyal MK, Lal V, et al. Role of plasma clusterin in alzheimer\u2019s disease-A pilot study in a tertiary hospital in Northern India. PLoS ONE. 2016;11:e0166369.","journal-title":"PLoS ONE"},{"key":"916_CR440","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3233\/JAD-160420","volume":"54","author":"S Hakobyan","year":"2016","unstructured":"Hakobyan S, Harding K, Aiyaz M, Hye A, Dobson R, Baird A, et al. Complement biomarkers as predictors of disease progression in alzheimer\u2019s disease. J Alzheimers Dis. 2016;54:707\u201316.","journal-title":"J Alzheimers Dis"},{"key":"916_CR441","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.molimm.2018.06.264","volume":"102","author":"AJ Tenner","year":"2018","unstructured":"Tenner AJ, Stevens B, Woodruff TM. New tricks for an ancient system: physiological and pathological roles of complement in the CNS. Mol Immunol. 2018;102:3\u201313.","journal-title":"Mol Immunol"},{"key":"916_CR442","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/JAD-2012-112012","volume":"30","author":"M Zabel","year":"2012","unstructured":"Zabel M, Schrag M, Mueller C, Zhou W, Crofton A, Petersen F, et al. Assessing candidate serum biomarkers for alzheimer\u2019s disease: a longitudinal study. J Alzheimers Dis. 2012;30:311\u201321.","journal-title":"J Alzheimers Dis"},{"key":"916_CR443","doi-asserted-by":"publisher","first-page":"429","DOI":"10.14336\/AD.2019.0119","volume":"10","author":"Y Ma","year":"2019","unstructured":"Ma Y, Liu Y, Zhang Z, Yang G-Y. Significance of complement system in ischemic stroke: A comprehensive review. Aging Dis. 2019;10:429\u201362.","journal-title":"Aging Dis"},{"key":"916_CR444","doi-asserted-by":"publisher","first-page":"110744","DOI":"10.1016\/j.intimp.2023.110744","volume":"123","author":"Y Li","year":"2023","unstructured":"Li Y, Tao C, An N, Liu H, Liu Z, Zhang H, et al. Revisiting the role of the complement system in intracerebral hemorrhage and therapeutic prospects. Int Immunopharmacol. 2023;123:110744.","journal-title":"Int Immunopharmacol"},{"key":"916_CR445","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12016-025-09027-4","volume":"68","author":"BL Zuraw","year":"2025","unstructured":"Zuraw BL, Bork K, Bouillet L, Christiansen SC, Farkas H, Germenis AE, et al. Hereditary angioedema with normal C1 inhibitor: an updated international consensus paper on diagnosis, pathophysiology, and treatment. Clin Rev Allergy Immunol. 2025;68:24.","journal-title":"Clin Rev Allergy Immunol"},{"key":"916_CR446","first-page":"249","volume":"21","author":"A Mullard","year":"2022","unstructured":"Mullard A. FDA approves first anti-C1s antibody, targeting innate immunity for rare anaemia. Nat Rev Drug Discovery. 2022;21:249\u2013249.","journal-title":"Nat Rev Drug Discovery"},{"key":"916_CR447","doi-asserted-by":"publisher","first-page":"8698","DOI":"10.3390\/ijms25168698","volume":"25","author":"R Horneff","year":"2024","unstructured":"Horneff R, Czech B, Yeh M, Surova E. Three years on: the role of Pegcetacoplan in paroxysmal nocturnal hemoglobinuria (PNH) since its initial approval. Int J Mol Sci. 2024;25:8698.","journal-title":"Int J Mol Sci"},{"key":"916_CR448","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","volume":"402","author":"JS Heier","year":"2023","unstructured":"Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, et al. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials. Lancet. 2023;402:1434\u201348.","journal-title":"Lancet"},{"key":"916_CR449","doi-asserted-by":"publisher","first-page":"204062072413075","DOI":"10.1177\/20406207241307500","volume":"15","author":"JJ Shi","year":"2024","unstructured":"Shi JJ, Ozcan YM, Santos CIA, Patel H, Shammo J, Bat T. Current landscape of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitors and regulators. Ther Adv Hematol. 2024;15:20406207241307500.","journal-title":"Ther Adv Hematol"},{"key":"916_CR450","doi-asserted-by":"publisher","first-page":"A1","DOI":"10.1016\/j.msard.2019.07.001","volume":"33","author":"S Pardo","year":"2019","unstructured":"Pardo S, Giovannoni G, Hawkes C, Lechner-Scott J, Waubant E, Levy M. Editorial on: Eculizumab in aquaporin-4-positive neuromyelitis Optica spectrum disorder. Mult Scler Relat Disord. 2019;33:A1\u20132.","journal-title":"Mult Scler Relat Disord"},{"key":"916_CR451","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1007\/s00415-023-11617-1","volume":"270","author":"T Vu","year":"2023","unstructured":"Vu T, Ortiz S, Katsuno M, Annane D, Mantegazza R, Beasley KN, et al. Ravulizumab pharmacokinetics and pharmacodynamics in patients with generalized myasthenia Gravis. J Neurol. 2023;270:3129\u201337.","journal-title":"J Neurol"},{"key":"916_CR452","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s40265-019-01068-2","volume":"79","author":"K McKeage","year":"2019","unstructured":"McKeage K, Ravulizumab. First global approval. Drugs. 2019;79:347\u201352.","journal-title":"Drugs"},{"issue":"16","key":"916_CR453","first-page":"1551","volume":"83","author":"SM Hoy","year":"2023","unstructured":"Hoy SM, Pozelimab. First Approval Drugs. 2023;83(16):1551\u20137.","journal-title":"First Approval Drugs"},{"issue":"6","key":"916_CR454","first-page":"707","volume":"84","author":"S Dhillon","year":"2024","unstructured":"Dhillon S, Crovalimab. First Approval Drugs. 2024;84(6):707\u201316.","journal-title":"First Approval Drugs"},{"issue":"1","key":"916_CR455","first-page":"99","volume":"84","author":"M Shirley","year":"2024","unstructured":"Shirley M, Zilucoplan. First Approval Drugs. 2024;84(1):99\u2013104.","journal-title":"First Approval Drugs"},{"issue":"Abstracts","key":"916_CR456","doi-asserted-by":"publisher","first-page":"A3110","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A3110","volume":"211","author":"RM Panas","year":"2025","unstructured":"Panas RM, Burnett BP, Chong C, Guo R, Riedemann N. Treatment of Viral-induced acute respiratory distress syndrome (ARDS) with vilobelimab: A focus on C5a Inhibition. Am J Respir Crit Care Med. 2025;211(Abstracts):A3110.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"916_CR457","first-page":"79","volume":"82","author":"A Lee","year":"2022","unstructured":"Lee A, Avacopan. First Approval Drugs. 2022;82(1):79\u201385.","journal-title":"First Approval Drugs"},{"issue":"5","key":"916_CR458","first-page":"599","volume":"84","author":"YY Syed","year":"2024","unstructured":"Syed YY, Iptacopan. First Approval Drugs. 2024;84(5):599\u2013606.","journal-title":"First Approval Drugs"},{"issue":"5","key":"916_CR459","first-page":"613","volume":"84","author":"C Kang","year":"2024","unstructured":"Kang C, Danicopan. First Approval Drugs. 2024;84(5):613\u20138.","journal-title":"First Approval Drugs"},{"key":"916_CR460","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1002\/alz.13857","volume":"20","author":"A Latif-Hernandez","year":"2024","unstructured":"Latif-Hernandez A, Yang T, Butler RR 3rd, Losada PM, Minhas PS, White H, et al. A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity-dependent synaptic and microglial transcriptomic changes in a late-stage alzheimer\u2019s mouse model. Alzheimers Dement. 2024;20:4434\u201360.","journal-title":"Alzheimers Dement"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00916-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00916-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00916-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:15:15Z","timestamp":1781622915000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13024-025-00916-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":460,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["916"],"URL":"https:\/\/doi.org\/10.1186\/s13024-025-00916-y","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"C.A.L. serves or has served within the past 3 years as a consultant or SAB member for Acumen Pharmaceuticals, ADvantage Therapeutics, Alnylam Pharmaceuticals, Apellis Pharmaceuticals, Biohaven Pharmaceuticals, Cyclo Therapeutics, Eli Lilly, Merck, MindImmune Therapeutics, Novo Nordisk, Receptive Bio, Sanofi, Switch Therapeutics, and Therini Bio. All other authors have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}